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The purpose of this report is to determine whether health maintenance organisations 
(HMOs) can provide a suitable and viable form of financial health protection and service 
provision in selected West African countries, supplementary to existing healthcare provision 
and coverage. Burkina Faso, Côte d’Ivoire, The Gambia, Guinea-Bissau, Liberia and Sierra 
Leone were chosen as country examples. Chapter 1 provides the context for the health and 
healthcare situation in West Africa as well as specific country profiles, whilst Chapter 2 
describes factors to be considered when establishing an HMO. The range of technical di-
mensions of an HMO introduced in this report includes: administration, human resources, 
financing, accreditation, service availability and readiness, the benefits catalogue, paying 
providers, drugs and quality management. Each of these dimensions is further discussed 
in Chapters 3 – 10.   
The administration of an HMO consists of nine interconnected fields: management dash-
board, quality management, IT department, purchasing and coordination, finance and ac-
counting, health plan and benefit package, member management, human resources, and 
marketing. In Chapter 3, the authors give a more in-depth analysis of the fields of marketing 
and member management. Recommendations provided in this chapter include the use of 
different marketing approaches to bridge the gap between communities and the HMO by 
establishing informative advertising (e.g., via a mobile responsive website, social media, 
posters, flyers, radio, and recorded information).  
Chapter 4 focuses on an HMO’s human resources, particularly in regard to staff recruiting, 
development and retention. Staff development expands staff competence by increasing em-
ployees’ motivation and job satisfaction, which leads to an increase in their performance 
and productivity, thereby improving staff retention. Furthermore, staff retention is important 
for ensuring a long-term commitment to the HMO. In conclusion, the success of an HMO is 
crucially dependent on motivating staff and enabling them to exercise, develop and share 
their skills.  
Chapter 5 covers the financial aspects of an HMO, including dimensions related to its target 
population, financial barriers, funding resources, management of funds, and specific coun-
try challenges. In order to calculate the necessary resources, this chapter make clear that 
an HMO must consider cost projections for the benefit package, infrastructure development, 
administration, expansion and a reserve.  
To establish an accreditation system, HMOs can interact with stakeholders from different 
fields and levels of service delivery and administration, as examined in Chapter 6. The po-
litical and social conditions of a country must be considered by the HMO in order to effec-




performance quality of healthcare by supporting the establishment of an accreditation 
scheme.  
Reliable information on service availability and readiness is necessary for successful health 
systems management as it allows health services to be tracked in terms of how they have 
responded to changed inputs and processes. In Chapter 7, the authors analyse the Service 
Availability and Readiness Assessment (SARA) tool, and recommend its application within 
the HMO, as it offers a standardised approach to monitoring the supply of services by 
providing a standard set of tracer indicators.  
To implement a health benefit package (HBP), the authors assess existing models, such as 
the one introduced by Glassman et al. (2017) which specifies ten core elements of an HBP 
design and helps to enable discussions on the most relevant aspects in designing an HBP 
for an HMO. Chapter 8 presents a coinsurance scheme within the HBP design which will 
affect the service utilisation of members as well as utilisation management as one method 
for cost control. In addition, actuarial calculations are proposed using Sierra Leone as a 
case example.  
Chapter 9 describes the pharmaceutical supply chain required by an HMO. Important steps 
of the HMO’s medicine supply chain include: selection, quantification and forecasting, pro-
curement, storage, and distribution of medical products. Medicines provided by the HMO 
must be safe, available, accessible, and affordable at all times and for all members. Stock-
outs must be avoided, and therefore this chapter recommends employing community-based 
health workers in order to ensure distribution to patients in rural areas.  
Quality management is an important field in an HMO analysed in Chapter 10 of this report. 
It includes patient safety, efficiency, and patient satisfaction; all factors that must be consid-
ered during the implementation of an HMO. The chapter concludes by noting that quality is 
highly subjective and must therefore be applied to the specific context of an HMO within a 
specific country.  
Finally, Chapters 11 and 12 of the report include implementation challenges of an HMO in 
West Africa, as well next steps that should be followed. Although similar challenges con-
cerning the social, political, or structural environment can be found in most West African 
countries, direct transfer of elaborated information to other countries and healthcare situa-
tions is not always possible. As well as these situational challenges, HMOs encounter dif-
ferent questions such as how to balance the scope of available services against the cover-
age of diverse geographical areas, engagement of various stakeholders and reflection of 
respective values, interests and perspectives of local populations.   
Limitations of the report include a lack of specificity in general, and the use of many specific 




be transferable to other regions and healthcare situations. Therefore, this report is not 
meant to provide concrete conclusions or solutions in regard to the implementation of an 
HMO in a specific country setting.  
In conclusion, this report states that HMOs have the potential to play a substantial role in 
healthcare system strengthening, provision of quality healthcare services and the preven-
tion of financial burden due to ill-health. As a result, an HMO can support West African 
countries in their role to fulfil their obligation of protecting the health of their citizens. Addi-
tionally, the authors strongly believe that an HMO must reflect the cultural, societal and 
political environment in which it is implemented. Therefore, it is essential that research be 
conducted prior to its implementation in addition to including the relevant local stakeholders 
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1 Health and healthcare in West Africa 
A health maintenance organisation (HMO) is a prepaid health plan that in contrast to other 
forms of service provision and insurance, combines financing and care delivery within one 
organisation with the aim of aligning the incentives of the health care provider and payer 
(Falkson/Srinivasan 2020). This report aims to establish where and how an HMO would be 
a suitable and viable form of financial health protection and service provision, supplemen-
tary to the existing healthcare provision and coverage in each respective West African coun-
try. 
Several characteristics of the West African situation, both general and health related, must 
be considered when establishing a healthcare system in the form of an HMO. This includes 
finding solutions for and setting priorities according to the burden of disease in these coun-
tries, which commonly include respiratory infections, diarrheal diseases, malaria and Hu-
man Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS). Further-
more, cost limitations of the population must be taken into account and it must be assured 
that those who most need care – in many cases the rural poor – are also addressed and 
included within the system. 
The following chapters will address a range of HMO dimensions, including: administration, 
human resources, financing, accreditation, service availability and readiness, the benefits 
catalogue, paying providers, drugs and quality management. A selection of West African 
countries, namely Burkina Faso, Côte d’Ivoire, The Gambia, Guinea-Bissau, Liberia and 
Sierra Leone will be used as country examples in order to illustrate an HMO implementation 
strategy as well as more country specific challenges. 
1.1 Background  
1.1.1 Demographics 
West Africa has been experiencing a huge demographic shift, being the last continent to 
experience sharp population growth into the 21st century. It is a region that is still rapidly 
growing, with the majority of population growth having been absorbed by West African cities 
(Sahel and West Africa Club/OECD 2006). The West African demographic is additionally 
characterised by a very young population, with people under age 25 counting for up to two 
thirds of the population in some countries such as Côte d’Ivoire, whilst in comparison the 
European continent and others are already in a stage of depopulation, and face instead 
issues an ageing population brings with it. The overall population of the West African region 
currently lies at 407 million, equating to just over five percent of the total world population, 
and has had a steady annual growth rate of between 2-3 % (Worldometer 2021a). Gross-
domestic product (GDP) per capita in the region fluctuates between US$ 622 in Liberia to 
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US$ 276 in Côte d’Ivoire (World Bank 2020b). Almost 50 % of the population is considered 
urban, and the median age lies at around 18 years. Life expectancy in the West African 
region lies at 57 for men, and 59 for women (Statista 2020), and the overall fertility rate 
currently sits at just over five. Infant mortality in West Africa is still decidedly high compared 
with the rest of the world, with rates ranging from 27 per 1000 live births in The Gambia, to 
87 per 1000 live births in Burkina Faso (IHME 2020a; IHME 2020b).   
When addressing the various HMO dimensions, it is important to consider these demo-
graphic factors within the West African region, as well as within the individual countries, in 
order to adjust service provision to the needs of the population. For example, the needs of 
young, urban members will be different to others who are perhaps ageing and live rurally. 
1.1.2 History, political context and culture  
West Africa has had a long and turbulent history, with a mix of influences and conquests 
from the Arab world, and later Europe. The slave trade between the 1600’s and early 1800’s 
also played a strong role. Colonisation of West Africa began in the 1800’s, predominantly 
by Britain and France, with the colonial period only ending as recently as the 20 th century 
(Fage/McCaskie 2020). For this reason, the majority of the countries in West Africa are still 
predominantly francophone or anglophone, alongside over 500 other indigenous lan-
guages. The postcolonial period up until today has also been littered with conflicts and civil 
wars, the roots of these issues being decidedly complex and “embedded in the interplay of 
historical factors, socio-economic crisis, legacies of authoritarianism and the politics of ex-
clusion, international forces, and local struggles” (Obi 2012). 
West Africa has up until recently been considered politically volatile, with civil wars and 
conflicts littering the 20th century. However, since achieving independence, the majority of 
these have been classified as intrastate conflicts, and overall, the political situation has sta-
bilised in the region (Marc et al. 2015). Although progress has been made in regards to 
democratic consolidation, there still exist a host of challenges affecting the political situation, 
such as the emergence of new threats related to drug-trafficking, religious extremism, wid-
ening inequalities, overall institutional weakness and poor governance. These challenges 
therefore underscore the huge progress made in economic growth, technical development, 
and participation in the globalised world. Due to the rapid economic growth in the region, 
and overall level of societal change, West African institutions are becoming increasingly 
strained, and it remains to be seen in which ways they will stand up to meet the needs of 
their increasingly young, urban and educated populations. 
When it comes to culture and society, West Africa is home to a complex mix of ethnic, 
religious, and linguistic groups. Due to its diversity, it is essential to understand the cultural 
differences between nations, regions, tribes and linguistic groups, rather than treating West 
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Africa as simply an undifferentiated whole (Lituchy/Michaud 2017). Islam is the predominant 
religion in the region, followed by Christianity, as well as a range of indigenous religions. 
Certain traditional cultural practices such as forced early marriage and female genital muti-
lation are still common in many parts of West Africa, and should also be taken into consid-
eration as to their impact on health (Amnesty International UK 2020). 
The historical background, political situation, and cultural complexity are all factors that must 
be considered when establishing an HMO. These factors set the context and underlying 
foundation in that they influence a country’s ability to provide health services, as well as 
general attitudes towards health. 
1.2 Disease burden  
Communicable diseases have always been a major driver of the leading causes of death in 
Africa. These include diseases such as malaria, lower respiratory infections, neonatal dis-
orders, diarrhoeal diseases, and tuberculosis. However, while in 1990 eight of the top ten 
causes of death were communicable diseases, the overall proportion has decreased to only 
five of ten, with a higher proportion of non-communicable diseases (NCDs) now placing 
among the top ten causes in 2017 (El Bcheraoui et al. 2020: 344f). This shift towards a 
higher burden of NCDs is consistent within the West African region, with ischemic heart 
diseases and stroke now placing among the top ten causes of death in all example coun-
tries. Other NCDs that occur more frequently (but not in all the countries) are congenital 
defects and cirrhosis, followed by hemoglobinopathies, which ranked among the top ten 
causes of death only in Burkina Faso (IHME 2020a).  
Although all countries are affected by similar causes of death and a rise of NCDs, they are 
all affected to varying degrees by these diseases. For example, although malaria placed 
among the top ten causes of death for all example countries, in Guinea-Bissau it was only 
in eighth place, whilst in the other countries it placed among the top three causes of death 
(IHME 2020c). Therefore, differing disease burdens such as these, as well as other country 
and gender specific factors such as population, age structure or differences in gender-spe-
cific vulnerability for diseases must be considered in order to enable a comprehensive 
health care delivery scheme. 
1.3 Health literacy and health-seeking behaviour 
The World Health Organisation (WHO) defines health literacy as: “the personal character-
istics and social resources needed for individuals and communities to access, understand, 
appraise and use information and services to make decisions about health” (WHO 2021a). 
Poor health literacy is associated with higher mortality rates (Bostock/Steptoe 2012: 3). 
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General consumer literacy levels regarding medicines in West Africa is very low, thus af-
fecting the rational use and awareness of safe medication. Many people in West Africa do 
not have adequate health literacy skills which indicates that there is low compliance when 
it comes to medication regulation and following advice regarding life-style habits 
(Amoah/Philips 2018: 44; Wångdahl/Mårtensson 2015: 165 f.). A study among adults in 
Ghana found that 40% of participants had inadequate health literacy, 26% problematic 
health literacy, and only 32% sufficient health literacy (Amoah/Philips 2018: 44).  However, 
literature is scarce and not always consistent. For example, another study conducted in 
Lagos State, Nigeria, displayed a higher health literacy rate of 75% (Kuyinu et al. 2020: 1).  
Health seeking behaviour can be described as “any action undertaken by individuals who 
perceive themselves to have a health problem or to be ill for the purpose of finding an ap-
propriate remedy” (Olenja 2003: 61). According to Kakkar et al. the utilisation of health care 
services is related to different socio-demographic factors. Examples for these are age, gen-
der, literacy- and socioeconomic status, availability, faith and education (Kakkar et al. 2013: 
139 ff.). In 2018, Nuhu found that health-seeking behaviour differs between people living in 
rural and urban areas. People living in urban areas are more likely to seek health care at a 
private health care facility. The same scientific work revealed that poor individuals tend to 
seek help from traditional/herbal practitioners more than individuals in higher income groups 
(Nuhu 2018: 163 f.). 
1.4 Public health context  
An important stakeholder in the West African region is the “Economic Community of West 
African States” (ECOWAS) with its health-specialised sub-organisation, the “West African 
Health Organisation” (WAHO), consisting of 15 member states (WAHO 2015: 12). These 
states have been trying to improve the health status of the population, but there is still a 
long way to go before all health needs are adequately addressed. The health situation of 
the region is currently characterised by high morbidity and mortality rates. Outbreaks of 
diseases like meningitis, cholera, yellow fever and measles have put pressure on the region. 
Particularly severe were the outbreaks of Ebola haemorrhagic fever between 2014 - 2016 
(WAHO 2015: 21). Affected countries were Guinea, Liberia, Sierra Leone, Mali, Nigeria and 
Senegal (CDC 2019). Approximately 11,000 of the 27,000 infected citizens died, including 
many healthcare workers, further weakening the health systems (Elston et al. 2017: 63; 
WAHO 2015: 1). Not only health systems, but also the economic and social situation dete-
riorated as a result of job losses and breakdown in the populations’ trust (Elston et al. 2017: 
61 ff.).  Mal- and undernutrition are other public health concerns in West-African countries 
and accountable for more than 50% of deaths occurring in children under five (WAHO 2015: 
21). Health care in West Africa is separated between public and private care. In 2011 the 
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growing private sector already provided about 60% of services in Benin and Nigeria. Ap-
proximately 70-80 % of ECOWAS inhabitants, especially people living in rural areas, use 
traditional medicine (WAHO 2015: 21 ff). On average 43 % of the health care spending is 
paid out-of-pocket (OOP), representing a huge burden on some population groups (WAHO 
2015: 22). Health care systems in West Africa face a diverse range of problems, including 
governance issues; financing shortages; brain drain; lack of qualified health care personnel, 
medical products and research; counterfeit medicines; and difficulties in communication, for 
instance, when it comes to border-crossing epidemics (WAHO 2015: 7). 
1.5 Pharmaceutical sector  
West African countries face similar challenges affecting drug manufacturing and the supply 
of medicines. Firstly, there is only a limited availability of qualified human resources, which 
is exacerbated by the problem of ‘brain drain’ due to poor remuneration (Ekeigwe 2019: 2). 
Additionally, lack of good infrastructure, high dependency on imported medical products 
and raw materials, difficulty to fulfil pre-qualifications set by the WHO, lack of research or-
ganisations, and financial as well as technical constraints are some of the factors hindering 
drug manufacturing in West Africa (WAHO 2014: 15 ff.). Furthermore, African countries 
purchase medical products at lower prices than developed markets do. Therefore, drug 
manufacturing in West Africa is a tough business with only small profit margins, meaning 
manufacturers are forced to become cost competitive in the international market (WAHO 
2014: 17). The medicine regulation system in West Africa is also poor, with unclear regula-
tory requirements regarding the registration of medicines that reflect the variety of lan-
guages in the region (WAHO 2014: 22). Counterfeit medicines are also a big challenge in 
the West African pharmaceutical sector, due to sales of medicines in open unregulated 
markets and a poor infrastructure for quality control (WAHO 2014: 25). In some countries, 
the incidence of counterfeit medicines was reported to be over 50%, leading to therapeutic 
failures and drug resistance (WAHO 2014: 22). Additionally, the pharmaceutical sector is 
poorly funded by the states, meaning most research activities for pharmaceutical develop-
ment are donor-funded and do not address the priorities of the ECOWAS region (WAHO 
2014: 26). 
To address these problems, the WAHO has developed an ECOWAS pharmaceutical plan, 
aiming to provide a strategic framework that can manage and regulate the pharmaceutical 
sector, so that self-sufficiency in production and the use of accessible, affordable, safe, and 
effective medical products can be provided (WAHO 2014: 28).When building up an HMO in 
West Africa, the challenges above need to be kept in mind, as well as the medicines supply 
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processes, to ensure they are in line with the framework provided by the WAHO. Addition-
ally, this pharmaceutical plan can serve as a strategic approach for the development of a 





Population    20 million (2019)  
GDP     US$ 16 billion (2019) 
GDP per capita  US$ 786 (2019) 
Current health expenditure 6% of GDP (2018) 
OOP of health expenditure 36% (2018) 




Life expectancy  
Female 62 years 
Male 60 years (2018) 
Birth rate  35 per 1,000 population (2020) 
Infant mortality  87 per 1,000 live births (2019) 
Maternal mortality  320 per 100,000 live births (2017) 
Physician density  0.1 per 1,000 inhabitants  
(IHME 2020a; Index mundi 2020a) 
The 5 leading causes of death (2019) 
1. Malaria 
2. Lower respiratory infect  
3. Neonatal disorders  
4. Diarrheal diseases 
5. Ischemic heart disease 
(IHME 2020a) 




Who funds health (2014)
Domestic funds
External funds
(Source: Own presentation after WHO 2016a: 42) 
Burkina Faso is located in the centre of West Africa 
and has borders to Mali, Côte d’Ivoire, Ghana, Togo, 
Benin and Niger. The population density is 76 inhab-
itants per km2, and the predominant part lives within 
urban areas (Worldometer 2020a). In rural areas, 
health infrastructure and services are poor, whereas 
urban regions are more privileged (Zon et al. 2020: 
7). The National Monitoring Committee has imple-
mented a national health development plan which 
focuses on maternal mortality, malaria and HIV con-
trol. Around 10% of the population is currently cov-
ered by some kind of health insurance (Bocoum et 







Population    26 million (2019)  
GDP     US$ 59 billion (2019) 
GDP per capita  US$ 2,276 (2019) 
Current health expenditure  4% of GDP (2018) 
OOP of health expenditure 39% (2018) 







Life expectancy  
Female 65 years 
Male 60 years (2018) 
Birth rate  36 per 1,000 population (2017) 
Infant mortality  47 per 1,000 live births (2019) 
Maternal mortality  614 per 100,000 live births (2019) 
Physician density  0.2 per 1,000 inhabitants  
(IHME 2020d; Index mundi 2020b) 
The 5 leading causes of death (2019) 
1. Malaria 
2. Neonatal disorders  
3. Lower respiratory infect  
4. HIV/AIDS 
5. Ischemic heart disease  
(IHME 2020d) 
(Lawler et al. 2021) 
90%
10%
Who funds health (2014)
Domestic funds
External funds
(Source: Own presentation after WHO 2016a: 50) 
Côte d’Ivoire is located on the south coast of West 
Africa, with borders to Guinea, Liberia, Mali, Burkina 
Faso, Ghana and the Atlantic Ocean. The country’s 
area comprises 318,000 km2, with a total population 
of about 26 million (Worldometer 2019). Public 
healthcare is divided into three levels. The primary 
level includes centres and clinics, whilst the second-
ary level comprises first referrals to regional, general 
and specialised hospitals. Teaching hospitals and 
specialised national institutes for second referral 
form the tertiary level. As less than 10% have ade-
quate health coverage, a National Health Insurance 
Fund has been implemented to manage and regu-






The Gambia  
Population   2 million (2020)  
GDP     US$ 2 billion (2019) 
GDP per capita  US$ 777 (2019) 
Current health expenditure   3% of GDP (2018) 
OOP of health expenditure 29% (2018) 






Life expectancy  
Female 68 years 
Male 64 years (2020) 
Birth rate  27 per 1,000 population (2020) 
Infant mortality  27 per 1,000 live births (2019) 
Maternal mortality  433 per 100,000 live births (2018) 
Physician density  0.1 per 1,000 inhabitants  
(IHME 2020b; Index mundi 2020c) 
The 5 leading causes of death (2019) 
1. Lower respiratory infect  
2. Ischemic heart disease  




(Clark et al. 2021) 
35%
65%
Who funds health (2014)
Domestic funds
External funds
(Source: Own presentation after WHO 2016a: 56) 
The Gambia is located in the western part of West 
Africa, surrounded by Senegal except for its western 
coast, by the Atlantic Ocean. With 10,000 km2, 
Gambia is the smallest country in Africa. Population 
density is 239 inhabitants per km2, and the predom-
inant part of inhabitants live within urban areas 
(Worldometer 2020b). Four percent of the Gambian 
population is currently covered by a health insur-
ance (Sine et al. 2019: 10). As for its important insti-
tutions, the Medical Research Council investigates 
tropical diseases, and the government has estab-
lished a medical school to qualify its own doctors 








Population    2 million (2020)  
GDP     US$ 1 billion (2018) 
GDP per capita  US$ 697 (2019) 
Current health expenditure   7% of GDP (2018) 
OOP of health expenditure 74% (2018) 









The 5 leading causes of death (2019) 
1. Neonatal disorders  
2. Diarrheal diseases  
3. Lower respiratory infect  
4. HIV/AIDS 
5. Ischemic heart disease  
(IHME 2020d) 
 
Life expectancy  
Female 63 years 
Male 58 years (2020) 
Birth rate  37 per 1,000 population (2020) 
Infant mortality  47 per 1,000 live births (2017) 
Maternal mortality  549 per 100,000 live births (2017) 
Physician density  0.1 per 1,000 inhabitants  
(IHME 2020d; Index mundi 2020d) 
(Galli et al. 2021) 
75%
25%
Who funds health (2014)
Domestic funds
External funds
(Source: Own presentation after WHO 2016a: 59) 
Guinea-Bissau is situated on the West African 
coast, with borders to Senegal, Guinea and the At-
lantic Ocean. Guinea-Bissau measures 28,000 km2 
with a total population of nearly 2 million (Worldome-
ter 2019). Public healthcare is delivered at three lev-
els. On the local level, primary healthcare is pro-
vided by health centres; on the secondary level, 
more specialised care is delivered by regional hos-
pitals; and lastly, located centrally is the national 
hospital which offers higher quality services and 
performs surgeries. The Health Sector Coordination 
Committee, international health initiatives and vari-
ous subsidies support the investments in Guinea-










Population    5 million (2020)  
GDP     US$ 3 billion (2019) 
GDP per capita  US$ 622 (2019) 
Current health expenditure   7% of GDP (2019) 
OOP of health expenditure 42% (2018) 












Life expectancy  
Female 67 years 
Male 62 years (2020) 
Birth rate  37 per 1,000 population (2021) 
Infant mortality  47 per 1,000 live births (2017) 
Maternal mortality  661 per 100,000 live births (2017) 
Physician density  < 0.1 per 1,000 inhabitants  
(The Worldfactbook 2021a; Index mundi 2020e) 
The 5 leading causes of death (2019) 
1. Malaria  
2. Diarrheal diseases  
3. Neonatal disorders  
4. Lower respiratory infect  
5. Ischemic heart disease 
(IHME 2020e) 
(Holsoe et al. 2021) 
Liberia is located on the western Atlantic coast of 
Africa and has borders to Guinea, Côte d’Ivoire and 
Sierra Leone, with a population density of around 53 
inhabitants per km2 (Worldometer 2020c). An em-
ployer-based health insurance currently covers 
around four to six percent of the Liberian population. 
The West African Health Organisation has collabo-
rated with the WHO and the International Health 
Regulations to implement the One Health approach, 
in order to strengthen the response to infectious dis-
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Sierra Leone  
 
Population    8 million (2020)  
GDP     US$ 4 billion (2019) 
GDP per capita  US$ 527 (2019) 
Current health expenditure 11% of GDP (2014) 
OOP of health expenditure 45% (2018) 






Life expectancy  
Female 61 years 
Male 59 years (2020) 
Birth rate  35 per 1,000 population (2020) 
Infant mortality  70 per 1,000 live births (2017) 
Maternal mortality  1,120 per 100,000 live births (2017) 
Physician density  < 0.1 per 1,000 inhabitants  
(IHME 2020f; Index mundi 2020f) 
The 5 leading causes of death (2019) 
1. Malaria  
2. Lower respiratory infect  
3. Neonatal disorders  
4. Ischemic heart disease  
5. Diarrheal diseases 
(IHME 2020f) 
(Nicol et al. 2021) 
80%
20%
Who funds health (2014)
Domestic funds
External funds
(Source: Own presentation after WHO 2016a: 76) 
Sierra Leone is located on the southwest coast of 
West Africa, with borders to Liberia, Guinea and the 
Atlantic Ocean. It has a total area of 72,000 km2, 
with around eight million inhabitants (Worldometer 
2019). The private health sector includes services at 
secondary and tertiary level in hospitals nationwide, 
whilst public facilities consist of hospitals and com-
munity health centres that cover various levels of 
care (Ministry of Health and Sanitation 2017). The 
Ministry of Health and Sanitation arranges the con-
trol of malaria and other infectious diseases. The 
National HIV/AIDS Secretariat is responsible for 
awareness, prevention and treatment methods 
within the country (Nicol et al. 2021). 
Health spending 
(IHME 2020f) 
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2 Establishing an HMO - relevancy, investment, and risk 
factors  
HMOs employ managed care strategies that emphasise prevention, detection, and treat-
ment of illnesses. Their objective is to provide health care delivery solutions through the 
continuum of care (Policy Scout 2021). HMOs represent one of the most integrated forms 
of managed care. This includes the, at least, partial integration of service financing and 
service provision. HMOs either take over the service provision or conclude selective con-
tracts with elected service providers to ensure service coverage for their members (Ame-
lung 2012: 66). These contract negotiations can amount to considerable discounts in ser-
vices. The HMO carries most of the financial risk for the service provision, but also directly 
influences and therefore controls quality and costs to a certain extent. One of the instru-
ments for this is using primary care physicians as the coordinator of patient care needs 
(Amelung 2012: 66). The following sub-chapters discuss the establishment of a private 
HMO in West Africa regarding relevancy, investment, and risk factors. 
2.1 Why a private HMO? 
Countries in West Africa often have insufficient resources in the field of health care which 
makes risk-sharing mechanisms especially important. Many health care services are fi-
nanced OOP by the respective population. The development of prepayment schemes to 
expand health insurance coverage and reduce OOP has been recommended by the Re-
gional Committee for Africa by the WHO (Carapinha et al. 2011: 2). In spite of the billions 
of dollars of international aid that have been distributed, an astonishing 50% of West Africa’s 
total health expenditure is financed by out-of-pocket payments (OOPs) by its population 
(WHO Regional Office for Africa 2013). For this reason, private HMOs represent an afford-
able and reasonable alternative.  
In general, an HMO will only cover costs sanctioned by the primary service provider. This 
makes it possible to have well maintained private facilities and provide all services needed 
due to the simplified demand planning (International Finance Corporation 2013: 7). Moreo-
ver, it is possible to have quick medical attention as most private healthcare facilities are 
less busy compared to public facilities. Efficient delivery of health care services and en-
hanced member engagement regarding the patients’ own health care should be provided. 
HMOs that typically provide basic insurance coverage coupled with selected preferred pro-
viders, are currently emerging throughout Sub-Saharan Africa. These usually involve a cap-
itation model or in-house provision of care. By providing in-house health services (generally 
primary care), these HMOs can control claimed costs and fraud more efficiently. Although 
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cost containment can make insurance affordable, the main development impact is the cre-
ation of incentives to catalyse the development of a larger provider network. Currently this 
model is best developed in Namibia, Nigeria, and Zimbabwe (International Finance Corpo-
ration 2013: 7).  
2.2 Sustainability of business, income & expenditure forecasts  
To answer the open question of the positive outcome of investing in an HMO in West Africa, 
one must look at the initial calculations on the sustainability and income of the HMO and its 
forecasted expenditure. The following information in regard to financing is discussed more 
in-depth in Chapter 6, as the purpose of this chapter is to provide an overview for investment 
purposes.  
First, when determining the target population of an HMO, sustainability must be considered. 
To achieve a high coverage in little time, the initial target area would be a high-density area 
such as capitals or big cities. Based on calculations from successful, existing HMO systems, 
the authors decided to set a monthly contribution rate of 6% of total income, an amount 
considered feasible for the target group of working members (Ministry of Health and Sani-
tation 2017: 55). With this steady contribution flow, the partial financial stability of the HMO 
would be ensured. With further development and calculating precision, the target group is 
able to be expanded. Sustainability is intricately connected to the second topic: income 
projections. This includes the allocation of financial resources based on revenue projec-
tions. With external contributors such as the World Bank, the Global Alliance for Vaccines 
and Immunisations (GAVI), and the Global Fund considered, an HMO in Guinea-Bissau 
was projected to achieve a total revenue of US$ 23 million (see 5.8). Lastly, the revenue 
must be broken down into different expenditure categories, with the contributory percentage 
being set according to need. Based on calculations and assumptions made by the authors, 
60% of the total budget would be allocated to the benefit package of the health plan, which 
covers various health areas and medical services. Reserve, administration, infrastructure, 
and expansion would each be assigned 10% of the budget (see 5.8). It is necessary to 
project expenditures at full capacity for these four categories during the implementation 
process of the HMO. With efficiency and standardisation, cutbacks in these areas can then 
be made.  
Hygeia Nigeria Limited is an example of a successful HMO implementation. Founded in 
2005, it is now one of the leading HMOs in Nigeria and other low- and middle-income coun-
tries (LMICs). In 2017, the company had an annual revenue of almost US$ 24 million (Dun 
& Bradstreet n. d.). Large companies invested heavily, such as the International Finance 
Corporation, and it was accredited by the National Health Insurance Scheme in Nigeria 
(International Finance Corporation 2016). Although the implementation process requires a 
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large capital investment, a private-for-profit HMO can still be of interest to global fund part-
ners looking to invest. In 2007, the Global Partnership on Output-Based Aid covered 70% 
of the project costs for implementing a pre-paid health scheme in Nigeria, which replicated 
the Hygeia concept (GPOBA 2007). With this contribution, a ten-year implementation period 
was enabled, which initially subsidised user premiums at 100%, and shifted to 0% subsidi-
sation at the end of the implementation period. This type of commitment from global funds 
emphasises the need for HMOs in this context, as well as their successful implementation 
model in LMICs. 
2.3 SWOT analysis 
A SWOT analysis serves as the basis for strategic planning before the implementation of a 
company. This analysis demonstrates the strengths and opportunities of an HMO in West 
Africa, as well as its weaknesses and existing threats (Table 1). The authors of this paper 
executed a SWOT analysis based on the information included in the following chapters to 
provide an overview of strategic planning considerations for the HMO implementation. 
Table 1: SWOT analysis of the implementation of an HMO in a LMIC in West Africa 
Strengths: 
▪ Nearly monopolistic position 
▪ High quality of health care 
▪ Wide range of various examinations and 
treatments  
▪ HMO run by West Africans 
Opportunities: 
▪ Emerging market  
▪ Many potential new members 
▪ Employee benefits as binding mechanism 
to HMO via health care plan provision 
▪ Successful examples as guidance 
Weaknesses: 
▪ Uncertainty in finding investors for initial 
capital 
▪ High initial investment with insufficient 
health infrastructure 
▪ Affordability/willingness to pay by the 
members 
▪ Economic dependency on external invest-
ments 
▪ Market uncertainty 
▪ Lack of qualified staff 
Threats: 
▪ Low enrolment 
▪ High burden of disease 
▪ Pandemics 
▪ Loss of investors 
▪ Health provider absenteeism  
▪ Safety hazards and political instability 
▪ Corruption   
(Source: Own presentation) 
The success of the HMO can be achieved by taking a closer look at individual parts of the 
analysis above. It is important to clarify which threats the HMO is exposed to as a result of 
its weaknesses. For example, this could include the low enrolment of members, as many 
people do not have the means or willingness to pay the fee. One way to minimise this threat 
would be to provide transparent and easily understandable information about the HMO and 
its services for future members. Through this, people will see the benefits of an HMO and 
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be more willing to join. In addition, payment by instalments could be offered so that mem-
bers can afford the membership even when they do not have enough money to pay the 
entire fee at once. Furthermore, it is important to look at whether the HMO is missing op-
portunities due to its weaknesses. While there is an emerging market with many new po-
tential members, there is also market uncertainty, because it cannot be accurately forecast 
whether the HMO will be well accepted by people. Therefore, the HMO’s weaknesses and 
risks need to be countered by its strengths. For example, due to the almost monopolistic 
position of the HMO in West Africa, it can be assumed that many people would join the 
HMO, as there is no alternative. In addition, a survey could be carried out regarding the 
residents' acceptance towards the HMO to counteract any uncertainty, before starting the 
implementation of the HMO. Finally, it must be clarified which strengths can be used to take 
advantage of opportunities. As the HMO is run by local people, there is the chance to bind 
them to the HMO using various benefits, such as a reduced membership fee for HMO em-
ployees. Overall, an HMOs weaknesses and threats must be addressed and minimised 







3 Administration  
The administration of an HMO usually tends to have some hierarchical structural features. 
To explain this structure, nine overall fields and their underlying objectives have been iden-
tified (Figure 1). Evidently, these fields are multilateral and interact with each other. Never-
theless, the authors tried to separately define fields to demonstrate the entire administration 
of an HMO.  
Figure 1: Overview of administration fields in an HMO 
(Source: Own presentation) 
The fields of marketing and member management were identified as most relevant and in 
need of further explanation and therefore will be focused on within the remainder of this 
chapter. 
3.1 Marketing 
Marketing is the first major key aspect in the field of administration of an HMO implemented 
in West Africa that needs to be considered. Marketing is the consistent alignment of the 
HMO to the needs of the respective target group (Wheelhouse Advisors 2020) and is es-
sential as it helps to advertise the respected services and builds a relationship between the 
HMO and the potential members. Moreover, the marketing strategy generates growth for 
the HMO, based on its resources and capabilities, by choosing the right approach (Tefen 
Management Consulting 2016).  
The first central step in the practice of marketing is the development and execution of a 
marketing strategy. A marketing strategy is a vision-driven, strategic detailed document that 
is meant to help facilitate the accomplishment of specific objectives, missions, and goals 




from different departments subscribe to internally, makes sure that all decision-makers are 
on the same page, streamlining the HMO and making operations more efficient. The de-
partments must work in tandem to achieve overall success (Reddy 2019). The first step of 
the marketing analysis is the identification of the state of the health industry as well as the 
existence of competitors in the same area. Moreover, the areas worth engaging in must be 
clarified and a layout of the environment must be set. By identifying the most common dis-
eases within the target population, the marketing plan can be specified further. An additional 
useful step towards a marketing approach is the establishment of a SWOT analysis; a stra-
tegic planning technique with four steps. It is used to help the HMO to identify strengths, 
weaknesses, opportunities, and threats related to project planning and marketing in partic-
ular (Vinerean 2017: 30f.).  
Figure 2: SWOT- Analysis of marketing within an HMO 
 
(Source: Own presentation after Reddy 2019)  
The market structure analysis is followed by an analysis of the members, including the iden-
tification of the member profile. Several question should be clarified: who are the potential 
members? What services do they desire? What is their main motivation to enrol? Lastly, all 
goals, objectives and plan of attack should be determined (Reddy 2019).   
Recruitment of members is crucial to the success of the HMO. Different marketing ap-
proaches can be applied and should be used simultaneously to cover the majority of the 
respective population (Morgan et al. 2019: 8). A revolutionary change has occurred in the 
way people gather information about services they are interested in, particularly in an online 
setting. The transition to more online services has created the opportunity to better com-
municate and interact with the target groups of an HMO (Vinerean 2017: 28ff.). Therefore, 
a user friendly and mobile responsive website is a key element in the field of marketing as 
a significant amount of people from West Africa own a phone, but only a small group of 




HMO’s contact details must be clearly indicated. Social media is another medium that offers 
a setting for creating a competitive advantage for relations between potential members and 
service providers or targeted audiences of an HMO. Social media marketing is a differenti-
ating factor for HMOs in online interactive settings, for a quality relationship (Vinerean 2017: 
30). Especially the platforms “Facebook” and “WhatsApp” are convenient as they have the 
highest numbers of users throughout Burkina Faso (Kemp 2020). Social media makes the 
HMO relatable, and the staff can interact with current or future members and build a repu-
tation. Posters and flyers in high density areas, and areas where people gather and spend 
time (e.g., market halls, public transport stations or hospitals) can also be beneficial. A con-
sistent and recognisable logo and/or slogan makes the HMO easily identifiable and word-
of-mouth will be ensured especially when the goal is explained successfully (Tefen Man-
agement Consulting 2017). However, there is a need for translators and recordings in dif-
ferent languages as most West African countries are home to a huge variety of languages. 
High rates of illiterates in West African settings make self-explanatory pictures a necessary 
inclusion (Statista 2018). Changes should be based on patient feedback through a diversity 
of channels. This demonstrates to members that the HMO values their opinion and is willing 
to take action based on the feedback. It should be made a priority, that every time feedback 
is received, it is collected and analysed, in line with the field of quality management (see 
Chapter 11) (Morgan et al. 2019: 6). The acoustic marketing will focus on using the radio, 
as it is one of the most popular mediums in Burkina Faso and West Africa in general. The 
radio has made it possible to reach people with low levels of literacy and those living in 
remote areas. The proliferation of stations and the popularity of programmes have given 
listeners a voice. The widespread use of mobile phones over the past decade has brought 
radio and listeners even closer, as the majority of people can react on air by calling or texting 
(Boudani 2020). Recorded information on the website and on social media will be placed 
next to the written texts. Employees of the HMO will distribute flyers and hold presentations 
in market stalls in different settlements of the countries. That ensures a high coverage, as 
even small villages have a rotation concept where the market takes place in a different 
location every day of the week (Aker/Fafchamps 2015: 263). All employees in the field of 
marketing must have a clear-cut understanding of the services and products, the necessity 
of them and how they are perceived by the target audience. That ensures a more efficient, 
cost-effective, and result-oriented marketing. 
The marketing of recruitment of staff will focus on using the HMO’s website, with a separate 
section for job offers. Online job boards which are mobile responsive will also be used to 
place job offers. Social media (especially WhatsApp and Facebook), university placement 
offices and secondary schools will be contact points for the potential future employees of 




schools, with an even smaller number of female students, which must be taken into consid-
eration in regard to marketing in secondary schools and universities (World Bank 2021b). 
The radio will be used again to reach a broad range of different people within the target 
population.  
Marketing in the case of recruitment of facilities will be focused mainly on the search for 
good quality facilities by observing daily procedures and processes within the facilities in 
Burkina Faso. The additional consideration of building new, optimally located facilities can 
also allow the accessibility for all members to be improved. Overall, the minimisation of 
travel costs in order to reach the facilities by HMO members can be reduced by building 
new, as well as recruiting optimally located, facilities (Severe Malaria Observatory 2019).  
Difficulties regarding marketing success could be due to the lack of trust in insurance-type 
arrangements as members pay in advance for a service that they may or may not receive 
(Dong et al. 2013: 850ff.). Moreover, there is an absence of a formal insurance culture in 
Burkina Faso and West Africa in general (WHO 2012). In many cases the target population 
will have weak financial capacities, making it essential to advertise the reduction of OOPs 
during enrolment (Dong et al. 2013: 850ff.).  
3.2 Member management 
The second key aspect for the administration of an HMO in a LMIC is the management of 
its members. In a LMIC context, this administrative field needs to be adequately adapted to 
current underlying conditions of the target population, which are mentioned in Chapter 1. 
Member management includes all administrative procedures with direct contact to the in-
sured person. The authors identified six overarching fields, which will be discussed in this 
chapter: enrolment, issuing of IDs, premium collection, member services, grievance proce-
dures, and accessibility. 
Enrolment deals with the eligibility and the unit of enrolment. The simplest forms of eligibility 
would be either citizenship, or residency, in the country. The former can be seen in the 
Ethiopian’s community-based health insurance (CBHI), and is usually used in public gov-
ernment-funded schemes (Feleke et al. 2015: 4). The latter can be seen in private or for-
profit health insurance schemes, which are more apparent in Kenya or Nigeria for example 
(Carapinha et al. 2011: 3), and more inclusive as they give access to several social groups, 
such as migrants and refugees. With a more widespread eligibility more people can be 
reached in the same geographic area. This would also include a more substantial money 
pool and broader risk sharing (van Hees et al. 2019: 12). In addition to the eligibility criteria, 
the unit of enrolment must be selected. The authors identified individual and household 
memberships as relevant for the HMO. Individual or person-specific memberships are com-




health insurance schemes only accept enrolment in private health insurance schemes on 
an individual basis. Oftentimes, insurance schemes for workforce exclude children, women 
staying at home or senior citizens. Within the context of this HMO and the massive social 
exclusion of specific vulnerable groups in health insurance schemes in LMICs, a single 
membership carries a high risk for adverse selection (van Hees et al. 2019: 11). An instru-
ment to tackle adverse selection is the enrolment at household level (van Hees et al. 2019: 
12). For example, the residents of each household and, depending on the HMO definition, 
sometimes including up to three non-residents, can pay a collective premium to enrol all 
members of the household. All members of the household can then access health services 
individually and are independent from the head of the household. These memberships are 
used in several health insurance schemes in developing countries with a growing enrolment 
rate and successful counteraction of adverse selection with the inclusion of higher risk mem-
bers of households (Carrin et al. 2005: 803). Therefore, the authors propose enrolment at 
household level for the HMO. 
With the enrolment criteria set, the HMO must ensure an accessible and feasible method 
of premium collection. This aspect is important to ensure the continuous membership of the 
HMO. A framework needs to consider the different geographical and systematic challenges 
for the premium collection. The collection process in LMICs is made difficult by the lack of 
digital financial services. Currently only about 43% of Sub-Saharan Africa have access to 
different modern options, such as mobile wallets or agent banking (World Bank 2018a). This 
number, which has grown at high rates over the last years, is still not sufficient for a finance 
strategy dependant on bank transfers. For this reason, a physical method of submitting 
premiums must be ensured. The most plausible way for this is the collection of premiums 
at local health facilities. The geographical barrier is the lowest at these facilities. With local 
money pooling instruments at hand, this would also enable the ability for local solidarity 
funds. Local health facility pools, in addition to the regular overall money fund, could subsi-
dise premiums of poorer households according to their definition and the needs of the com-
munity (Wang/Rosemberg 2018: 25). Remittances from foreign sources also play an im-
portant role in countries with high emigration rates. According to the World Bank, Burkina 
Faso had a net migration of approximately 125.000 people in 2017 (World Bank 2019a). 
Money transfers would therefore enable people to cover the premiums of families or rela-
tives living in Burkina Faso using income earned outside of the country. In addition to the 
collection process, the collection period requires close consideration and should not be 
generalised. For a monthly or yearly collection period different benefits apply. In some con-
texts, as demonstrated by Ethiopia, a monthly collection period works best as a monthly 
premium poses a lower barrier compared with a yearly premium of one large payment all at 
once (Feleke et al. 2015: 4). In Tanzania on the other hand, a yearly payment system has 




26). With crop harvest comes income, allowing payments to be made, whereas monthly 
payments could stop during droughts or awaiting harvests and prevent continued enrol-
ment. LMICs, such as Guinea-Bissau, rely mainly on this type of income with over 67% of 
employment in agriculture in 2020 (World Bank 2020g). Furthermore, premium collection 
also addresses risk management. Ethiopia’s CBHI offers a comparable example of this. 
Within this scheme, enrolees have a one-month waiting period after enrolment before they 
can access the covered health services (Feleke et al. 2015: 4). This fortifies enrolment be-
fore sickness. Due to the initial target group being highly populated areas such as capitals 
and big cities, a monthly premium collection at local health facilities with the possibility to 
transfer contribution payments also from out-of-state and a one-month waiting period after 
enrolment was identified as the most suitable solution for the HMO.  
In 2018, the World Bank published a paper in which the importance of identification (ID) for 
health in LMICs is explained and knowledge regarding emerging health sectors is summa-
rised (World Bank 2018b). The authentication of enrolment to access covered services is 
considered an essential factor, as health insurers need to be able to identify enrolled pa-
tients. With an ID, quality of treatment and efficiency of patient management can be im-
proved and strengthened. This can also be used for medical records and treatment histo-
ries. Overall, an ID facilitates usage of health services for patients and for medical staff, 
reduces fraud and improves data collection, which can be used for statistical purposes. All 
of this enables planning, evaluation, emergency response, improved treatments, and dis-
ease management. For the application of an identification system there are two options. 
Firstly, the creation of a health-specific functional identification system, such as an elec-
tronic health record or other mobile health applications. This could be in the form of a health 
card for every insured person. Implementing a new system requires a lot of administrational 
resources and if the resources are not available for proper implementation, the mentioned 
benefits will most likely be forfeited, with inferior care being the result. A stand-alone system 
often “cannot communicate, transfer data or records, or aggregate data between or within 
facilities” (World Bank 2018b: 1). Hence, the authors decided the second option would be 
more suitable for the HMO, namely the usage of existing foundational identification systems 
as basis for a health ID. Existing systems can take the form of national ID cards, population 
registers or unique identification numbers. This has been successfully done in many coun-
tries, such as Botswana with identification for HIV/AIDs care, or in Thailand with combining 
different databases for a universal healthcare registry (World Bank 2018b: 2). This can elim-
inate health-ID specific costs with an increase in efficiency and enables opportunities for 
interoperability with other databases, for instance, for social aid or similar governmental 
systems. Nevertheless, potential drawbacks are not excluded. Some countries are strug-




ID systems. In Chad, for example, there are no centralised archives of civil registration in-
formation and the records are scattered throughout the country, and in 2017 the estimated 
registration rate was at 40% (World Bank 2017: 10). In addition to that, an overarching 
database can pose as a privacy hazard if the system is not safe. For these reasons, a target 
population with a safe and successfully implemented ID system with a coverage of above 
70% is recommended by the authors. 
The fourth field is member services or care. This entails any kind of support for insured 
people. The range of member services includes help with completing contracts, support for 
technical or membership issues, and the assistance of members in finding doctors and care 
that meet their needs. Member service is the helping hand for any occurring questions and 
problems and therefore needs to be connected via phone but also via physical access to 
ensure accessibility for everyone. The authors agreed a call centre with email access and 
approachable offices at main health facilities would be the best possible realisation of mem-
ber service. 
Connected with member services is the field of grievance procedures. A grievance is, in 
short, a complaint management system including processing and evaluation of complaint 
for improvement (CMS 2020: 18f). Complaints can concern aspects related to provision of 
health care or prescription drug services, issues regarding the health care plan or any ac-
cessibility remarks. With a changing environment and many varying factors, as is the case 
in LMICs, a complaint management is necessary to ensure that the community is engaged 
in adapting health care plans to their needs. Resources for member services should also 
be used for grievance procedures and grievances need to be evaluated on a regular basis 
for possible improvement proposals. 
Key messages: 
➢ The administration of an HMO consists of nine interconnected fields: management 
dashboard, quality management, IT department, purchasing and coordination, fi-
nance and accounting, health plan and benefit package, member management, 
human resources, and marketing. 
➢ Different marketing approaches should be used to bridge the gap between com-
munities and HMO by establishing informative advertising (e.g., mobile respon-
sive website, social media, posters, flyers, radio, recorded information). 
➢ An HMO’s member management includes enrolment, issuing IDs, premium col-
lection, member services, grievance procedure, and accessibility – all of which 





4 Human resources  
Human resource management describes the optimal use of staff with the aim of contributing 
to the company's success. It can be defined as “a strategic and coherent approach to the 
management of an organisation’s most valued assets – the people working there who indi-
vidually and collectively contribute to the achievement of its objectives” (Armstrong 2006: 
3). The goal of human resource management is that an organisation achieves success with 
the contribution of its staff (Lindner-Lohmann et al. 2016: 1). Human resource management 
of an HMO can include the several subtopics. First, the staff of the HMO must be recruited, 
especially medical staff and administrators, a process which includes both marketing and 
application. Second, staff controlling is needed with planning, supervision, and navigation 
of the staff. Finally, staff retention with incentives and renumeration and staff development 
with promotions, job design and further staff education are also extremely useful (Lindner-
Lohmann et al. 2016: 5ff.). The following sections will explain staff development and staff 
retention in more detail; two essential topics for an HMO. 
4.1 Staff development 
Staff development is the totality of all measures and activities which serve to harmonise the 
company’s requirements with the abilities, skills, motivations, and behaviour of the staff 
(Lindner-Lohmann et al. 2016: 162). There are various objectives of staff development, 
these can include for example to support the achievement of the organisation’s goals, to 
meet the demand for professional and managerial staff, to improve the flexibility and per-
formance of employees and the motivation and retention of staff (Lindner-Lohmann et al. 
2016: 164; Kauffeld/Grote 2011: 114). There are many different measures that can be used 
for staff development, as listed below. 
4.1.1 Staff interviews 
Staff interviews are an important measure of staff development, in order to stimulate an 
exchange between a supervisor and their staff on a regular basis. The interviews are used 
to talk about the work- and professional situation, which gives the staff orientation about 
their location in the organisation and personal perspectives. Furthermore, it promotes their 
ability to identify with the company and its goals. In addition, staff interviews can be used to 
analyse problems and difficulties and discuss possibilities for improvement. It is also used 
to agree on new objectives, to address strengths and weaknesses of staff and supervisors 




4.1.2 Mentoring and coaching 
Mentoring and coaching is especially important for an HMO in West Africa as the education 
standard is not as high as in European countries and there is a lack of resources for edu-
cation (UNESCO Institute for Statistics 2019). Some well-educated staff members can take 
on the role of coaches and mentors and train other staff members. Coaching is important 
for personal and professional development and is mostly used for members with manage-
ment tasks. A coach is a process consultant and uses a variety of methods (Lancer et al. 
2016: 5ff.). In the HMO context, coaching could be used for managers of the HMO or heads 
of departments. In addition, mentoring could also be used to integrate new staff into the 
organisation and teach them new skills. A mentor is always an experienced member of the 
organisation that gives advice based on their experience in the organisation (Lancer et al. 
2016: 5ff.). Mentoring can therefore be used for new organisation members in lower posi-
tions like nurses, administrators, and people without formal education. Mentoring and 
coaching make it possible to hire people with low formal education and train them over time. 
4.1.3 Job design 
Job design is another important measure for educating staff, which often includes four com-
mon designs. One design is called job enrichment, where additional tasks of varying de-
grees of difficulty are given to the staff, requiring them to take over planning, decisions, and 
control over time (Schreyögg/Reuther 1997: 326). A second design is called job enlarge-
ment, and involves tasks being expanded with different yet similar tasks in order to counter 
monotony. Thirdly, job rotation of staff can be scheduled, allowing them to change their 
workplace (Schreyögg/Reuther 1997: 325) and giving staff the opportunity to get to know 
all areas of the HMO and flexibly change their work area when needed. For example, due 
to job rotation, nurses can become familiar with all stations in the hospital, and administra-
tors with all stations in the administration of the HMO. This could be useful if some staff 
members are unable to come to work. Finally, semi-autonomous working groups can be 
used as a job design, in which staff members can decide independently on the allocation of 
tasks. This relieves supervisors of delivering work instructions as the group is able to or-
ganise itself (Schreyögg/Reuther 1997: 327). 
4.1.4 Training programmes 
In addition to the above-mentioned aspects, it is extremely useful to implement a range of 
training programmes to develop staff. This allows staff to continue their education without 
leaving the organisation (Schäferhoff 2014). There are a number of different training pro-




The HMO could offer language courses to improve the communication between staff mem-
bers, seeing as many different languages are spoken in West Africa (Brenzinger 2005). 
Microsoft Office courses would also be an additional useful training tool, as many people 
do not have access to a home computer and are not well educated in this area of work 
(Statista 2021). Moreover, the HMO could offer their staff financial support towards the at-
tendance of university courses. As many people cannot afford university courses this would 
provide them the chance to further educate themselves. Soft skill training and leadership 
coaching are also useful training programmes.  
4.2 Staff retention 
Staff retention is an important aspect of internal human resource marketing and is the de-
sired outcome of staff support. The primary goal is to secure the commitment of staff, both 
now and in the future (Lippold 2015: 29). The benefits of successful staff retention include 
preserving knowledge and know-how and reducing costs through less staff turnover. This 
also leads to less stress and burnout, fewer sick days among the workforce, and helps to 
create a good working atmosphere. Other aspects include better quality of performed work 
and as a result the better reputation of the company (Frey 2013: 103). 
4.2.1 Intrinsic motivation 
The behaviour of staff is dependent on their inner motivation regarding actions. In addition, 
intrinsic actions are associated with a positive feeling, as it enables the acting person to 
self-actualise (Kunz/Quitmann 2011: 58). Therefore, promoting and stimulating internal mo-
tivation is essential for long-term staff retention and consequently contributes to an efficient 
and high-performing workforce. Retaining staff for an HMO additionally requires considera-
tion of country-specific factors. In some countries people often live in fear of terror and, 
especially in the more rural areas, even the basic physiological needs cannot always be 
satisfied (OSAC 2020). In order to enable the staff to achieve the main goal of self-actuali-
sation, the HMO can start by providing its staff with free water, food and work clothes. In 
addition, it is important to provide stability by guaranteeing job security, so that the fear of 
losing income can be reduced. Besides meeting basic needs, the HMO should also offer 
corporate incentives. These can be incentives within the organisational environment, the 
work itself, as well as social and financial incentives.  
4.2.2 Corporate incentives 
Examples of corporate incentives are corporate culture, social climate, the work itself and 
remuneration (Lippold 2015: 32). Implementing an appreciative corporate culture is essen-
tial in order to work together productively. This requires the staff to be able to identify with 




54). Corporate culture also includes diversity management. Diversity management ensures 
equality and appreciation of each staff member. Its task is to prevent any discrimination 
based on age, cultural origin, religion, disabilities or gender, and to respect the needs and 
interests of each employee (Franken 2015: 11ff.). In an HMO, many people from different 
countries and backgrounds work together, therefore mutual acceptance and cooperation 
are important for a healthy social climate in the workplace (Badura et al. 2010: 53ff.). Cor-
porate incentives can further be divided into tangible incentives, such as remuneration, and 
intangible incentives, such as the work itself (Lippold 2015: 32). 
When considering the possibilities for these incentives, many aspects can be listed. An 
HMO might offer multiple options regarding remuneration, for example, that staff can use 
the services free of charge. Additionally, close family members might not have to pay the 
full price either. If regionally possible, travel costs should be covered by public transport up 
to a certain amount. Funds for scholarships to support good students are also a useful 
measure to retain them as staff later on. The provision of a car for doctors to make house 
calls is also conceivable. On the other hand, there are also many opportunities for intangible 
incentives. As a reliable employer, the HMO is a safe choice for staff. Professional devel-
opment and training can be provided. In addition, high-quality equipment is used. In-house 
day care also allows mothers to work. 
4.2.3 Occupational health management 
In addition to motivating staff, it is also important for every company to take care of the 
health of its staff at work. Occupational health management promotes the health of the staff 
during work and educates them to behave in a health-promoting manner (Badura et al. 
2010: 33). Measures considered useful in the context of an HMO include hiring a psycholo-
gist and physiotherapist to maintain mental and physical health. Ergonomic keyboards, for 
office workers and ergonomic operating chairs, for doctors can also be provided, in addition 
to an addiction prevention programme and occupational safety measures. 
Key messages: 
➢ Staff development expands staff competence, which increases their motivation 
and job satisfaction leading to an increase of performance and productivity im-
proved staff retention.  
➢ Comprehensive staff development makes the HMO more attractive for potential 
new staff and gives it a competitive advantage over other organisations. 
➢ Staff retention is important for ensuring a long-term commitment to the company. 
Motivating staff and enabling them to exercise, develop and share their skills will 




5 Financing  
This section of the report will focus on financing issues that need to be considered in order 
to set up an HMO successfully. 
5.1 Financial barriers 
The highest burden on financing of health services is caused by informal payments, pre-
dominantly found in African countries. In the health sector, informal payments can include 
cost-contribution payments, solicited unofficial salary supplements and unsolicited dona-
tions. Consequently, equity and quality are impacted, and the efficiency of services are un-
dermined. Most often, informal payment services are used by individuals that are not able 
to afford official services, which can lead to delayed or even withheld treatment if no finan-
cial resources are available. Especially in rural areas healthcare is often insufficiently or-
ganised and many patients lack proper education and information in regard to user fees in 
order to recognise exorbitant prices. An estimated 10% to 45% of informal payments in 
Guinea-Bissau are comprised of OOP payments, which is a convenient coping mechanism 
for informal health workers with poor working conditions and low or irregular salaries (Kitson 
2019: 7 f.) 
West African countries show a strong dependency on external aid for health budgets, as 
statutory contributions are limited to a minimum and may not even cover the salaries of the 
whole health workforce (WHO 2016b: 1). A need for action and the reconsideration of cur-
rent financing policies are essential in order to overcome financial barriers, with the overall 
goal to improve equity, efficiency and quality of care for every citizen. Most importantly, 
sustainable, well-functioning and long-term health financing systems must be established 
(Kitson 2019: 23 f.). 
5.2 Funding 
Funding can be understood as the process of revenue collection. It is feasible to differentiate 
between who is paying, what kind of payment is being made and who collects the resources 
(Mossialos/Dixon 2002: 4). The provision of a basic package of essential services and fi-
nancial protection against catastrophic financial losses through illness or crop failures 
should be considered when collecting and raising sufficient revenue (Salehi 2010: 10).  
Major challenges in funding an HMO are demonstrated by difficulties in increasing available 
funds in order to provide sufficient, accessible and quality health services. Possible solu-
tions can include the expansion of domestic funds or the diversification of the country’s 
funding sources. Therefore, governments should give health a higher priority when allocat-




5.3 Further funding resources  
When national funding resources are limited, external investments become more important 
for financing an HMO. This frequently includes investments by international donors, non-
governmental organisations (NGOs), and other private donors, often provided by ear-
marked programmes with specific targets. In Guinea-Bissau, all three sources of external 
investments mentioned are present and necessary, as health financing depends principally 
on external aid. Huge external financial resources are contributed by the World Bank (World 
Bank 2021c), GAVI (GAVI 2020) and the Global Fund (The Global Fund 2021). In some 
cases, patients are supported financially by earmarked programmes for specific health is-
sues (World Bank 2019b: 24 f.). There are also earmarked programmes with a focus on 
maternal and child health, which guarantee healthcare free of charge for these population 
groups (European Commission 2021, UHC2030 2021).  
The authors of this publication estimate, that approximately 5,6 % (US$ 1.25 million) of the 
overall budget from this HMO will derive from allocations by external, governmental and 
non-governmental partners. Figure 3 illustrates the expected proportion each of these part-
ners will contribute to the external funding of the presented HMO. 
Figure 3: Share contributed by different partners to the external funding of HMO 
 
(Source: Own presentation after Russo et al. 2017; World Bank 2021c; GAVI 2020; Global 
Fund 2021) 
5.4 Pooling  
Pooling is defined as “the accumulation of prepaid healthcare revenues on behalf of a pop-
ulation” (Kutzin 2001: 177). In other words, this means that different revenue streams such 
as donations and contributions are collected in advance and put into one ‘pot’ to finance the 












Pooling of financial resources is an important financing opportunity for HMOs due to the 
following advantages (CABRI 2005; Kutzin 2001: 177 ff.): 
• Enables complementarity of different funding sources (defragmentation) 
• Allows the possibility of administering different funding resources 
• Simplifies financial flows 
• Secures the cross-subsidisation of available prepaid funds and therefore enhances 
insurance member equity in financing and access  
• Reduces risk if a resource dissipates and therefore supports viability of an HMO 
To benefit from these pooling advantages, it is essential to have technical equipment and 
regional experts for the management of pooling systems in place. 
5.5 Allocation of funds 
The allocation process encourages the purchase of health services to be strategic, and 
allocatively and technically effective (Salehi 2010: 10), for which the following questions 
need to be asked. Are funds allocated in a way that healthcare needs are met? Which 
population size, gender or age groups should be covered? Which institutions are required? 
To answer these questions, several steps need to be considered during allocation. First of 
all, alignment issues, which relate to how revenue aligns with other sectors or the benefit 
package. Secondly, purchasing services, for instance how to allocate financial resources to 
different health service providers. And lastly, the flow of funds, which should have a clear 
structure from the funding source through to the pooling and purchasing mechanisms. Due 
to these reasons, the provider payment system and market structure, together with organi-
sational setup between purchasers and providers, need to be taken into account (WHO 
2017a: 14 ff.). In LMICs, HMOs should consider population groups with the lowest income, 
families, and populations living in rural areas as well as facilities with the lowest infrastruc-
ture. The role traditional medicine and traditional healers play must also be taken into ac-
count, as often rural populations put more trust in and are familiar with these services (Diniz 
et al. 1994: 729). 
5.6 Calculation 
When calculating financial resources for an HMO, several issues need to be considered: 
• Which external financial resources are available? 
• How much money does the government spend on the health system?  
• How much money can be raised by population contributions?  




As resources are limited, the set up and maintenance of a successful HMO is insecure, and 
the risk of miscalculation high. This makes it necessary to calculate conservatively, espe-
cially during the launch phases of the insurance, in order to forecast how much money, and 
from which resources, will be available for the final allocation. Next, the overall financial 
capacity and distribution of spending for 2020 will be demonstrated using the example of 
Guinea-Bissau. The underlying actuarial calculations are presented in Appendix 1 “Actuarial 
calculations – Guinea-Bissau". 
Currently, Guinea-Bissau has a population of two million people, with an average growth 
rate of 2.5% (Figure 4). The selected population to be covered by the HMO are those work-
ing and living in the capital, Bissau, between the ages of 15 to 64. This population group, 
comprising of 214,000 individuals, has been considered suitable for covering contribution 
payments. Usually, education is compulsory and free for individuals until the age of 15, after 
which secondary and higher education is possible but certainly not given, and is mostly 
carried out abroad due to higher quality (Nichols 2021). After the HMO has been imple-
mented and is working well, coverage can be extended to include further population groups. 
Figure 4: Population projections Guinea-Bissau 
 
(Source: Own presentation after United Nations 2019; Worldometer 2021b) 
Revenue projections consist of different funding sources and contributors (Table 2). With 
an annual average income of Bissau’s working population of around US$ 1,700, of which 
6% is contributed to the HMO yearly, around US$ 21 million would be generated annually. 
Additional external resources, comprising governmental and non-governmental revenues 
are also relevant for the calculation. Non-governmental revenues consist of international 
donors like GAVI, the Global Fund and the World Bank, as well as private donors and ear-
marked funds. Governmental revenues are covered by the Ministry of Health and the pop-
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million through all external revenues; of which 5% would be allocated to the HMO. This 5% 
allocation rate is based on calculations carried out by other successfully implemented 
HMOs in order to integrate them into the national health care system (Ministry of Health and 
Sanitation 2017: 55). This percentage of external resources, together with the formal con-
tributions of the population, would annually result in an estimated US$ 22.25 million availa-
ble for allocation by the HMO. 
Table 2: Revenue projections Guinea Bissau 
Formal contributions  
Number of contributors 214,000 
Average yearly insurable income per contributor US$ 1,670 
Contribution rate 6% 
Average contribution per contributor per year US$ 100 
Total sum  US$ 21 million 
 
External resources (yearly budget in US$) 
Governmental revenues 
Ministry of Health  23,000 
Population income tax 5 million 
Percentage allocated to HMO 5% 
Total sum  251,000 
Non-governmental revenues 
International Donors  
World Bank  433,000 
GAVI 1.69 million 
Global Fund 18 million 
Percentage allocated to HMO 5% 
Total sum 1 million 
 
Total HMO revenue 22.25 million  
(Source: Own presentation after Russo et al. 2017; World Bank 2019b; World Bank 2020d; 
GAVI 2020; The Global Fund 2020) 
The next step of the calculation is the benefit cost projection, where the financing of various 
sectors and services needs to be considered. Five categories were selected for this, based 
on research by the authors, towards which the total budget would be allocated (Figure 5). 
Firstly, the benefit package, which covers various health areas and medical services, would 
be allocated 60% of the total budget. Additionally, 10% of the budget would be assigned to 
each of the remaining categories: infrastructure, administration, expansion and reserve. A 
reserve is essential in case any funding sources or income contributions are cutback. Based 
on these calculations, the HMO would reach an average annual per capita cost of approxi-




Figure 5: Benefit cost projection (in millions) 
 
(Source: Own presentation after actuarial calculation in Appendix 1) 
In the final step of the actuarial calculation, an actuarial balance is required. This balance 
is essential for demonstrating whether the entire cash outflow can be covered by the cash 
inflow, composing of population contributions as well as internal and external contributions. 
A complete actuarial calculation is required in order to determine if the implementation of 
an HMO in a West African country is economically feasible.   
Key messages: 
➢ The target population, financial barriers, funding resources, management of 
funds, and specific country challenges must be considered in regard to an HMO’s 
financing. 
➢ Requirements for optimising internal funding relevant to an HMO include: more 
health-related government investment, sensitisation, a health supporting tax sys-
tem, and less informal and OOPs. 
➢ To calculate the required funding, an HMO must consider cost projections for the 

















Accreditation is described as a process of official public acknowledgement by a mandated 
healthcare body. Initially an assessment of the level of performance in comparison to set 
standards to improve the overall performance is required to achieve this (Mansour et al. 
2020: 1 and 9). However, as little information was available in regard to current accreditation 
schemes in West Africa, the following section will examine overall accreditation aims and 
relevant actors. Additionally, existing schemes in other countries will be presented, in regard 
to their potential implementation within an HMO in Côte d’Ivoire.  
6.1 Aims 
Having the overall goal of quality improvement in the health sector in mind, accreditation 
schemes aim to enhance the public accountability of healthcare organisations. This can be 
achieved by putting the Ministry of Health (MoH) in place as an accreditation body to over-
see the initial assessment, and as a standard setting institution. Accreditation schemes can 
also be used as improvement tools (Mansour et al. 2020: 9). This accounts for both the 
public and private sector if i.e., an accreditation system is linked with a hospitals reimburse-
ment scheme to drive improvements. Furthermore, accreditation can be used as an indica-
tor for internationally high-performance (Mansour et al. 2020: 9). This is of special interest 
in the field of medical tourism if it is assumed that patients are seeking the best quality care, 
and therefore use international accreditation schemes as a marker for this. 
6.2 Involvement 
For the successful implementation and maintenance of an accreditation scheme, actors 
from different levels and fields are needed. Figure 6 shows the different levels of govern-
ance from a service delivery and administration perspective in Côte d’Ivoire, which must be 
considered depending on the given circumstances. Furthermore, the stakeholders can be 
assigned to different categories depending on their level of governance. As mentioned 
above, the MoH is a possible actor who would be classified on a national governmental 
level. The MoH can help maintaining financial and political support which subsequently en-
ables more sustainable programmes. Also, if used as an accreditation body, it avoids the 
financial burden of additionally implementing such an entity (Mansour et al. 2020: 11 f.). 
National stakeholders from a service delivery perspective can include health professional 
associations in Côte d’Ivoire. These could be i.e., regional or national physician associations 
whose objective it is to “direct all available national resources toward one common strategic 
objective that is improving the quality of care” (Mansour et al. 2020: 11 f.). International 




Foundation – or help by providing technical support to government and health care organi-
sations in the form of health expert consultants (Mansour et al. 2020: 11 f.). An HMO there-
fore needs to approach and collaborate with these different levels of actors in order to en-
sure an effective accreditation scheme. 
Figure 6: Governance structure of the Ivorian health system 
(Source: Duran et al. 2020: 42) 
6.3 Hospital accreditation 
The first example of an existing accreditation scheme can be seen in Liberia. The accredi-
tation system was planned and implemented by the Liberian Ministry of Health and Social 
Welfare as a component of the broader “Basic Package of Health Service”. The scheme 
aims to evaluate existing services and critical management systems and therefore demon-
strate areas of improvement (Cleveland et al. 20011: 272). Table 3 presents the nine cate-
gories under which health facilities were assessed, including their specific weight within the 
overall facility score. For example, the category of health services was most weighted, as 
these are the services required under the compulsory “Basic Package of Health Service” 
(Cleveland et al. 2011: 274). Based on the assigned scores and their weighting, an overall 
facility score was calculated. Depending on the score, certification using stars were granted 
as a symbol of accreditation, with an overall facility score of 75% or above being awarded 
a “Bronze ½ Star”, 85% a “Silver 1 Star” and facilities which met all requirements a “Gold 2 
Star” (Cleveland et al. 2011: 275). The accreditation scheme resulted in “unprecedented 
amounts of comprehensive, timely and detailed information […]” (Cleveland et al. 2011: 




was made possible. It also showed potential strengths, weaknesses and areas of improve-
ment while increasing accountability. It is important to note that major investments in labor-
atory capacities were made following the accreditation assessment, as all facilities scored 
relatively low in this category and this apparent weakness was revealed (Cleveland et al. 
2011: 276 f.). In Côte d’Ivoire this type of accreditation scheme could be carried out in co-
operation with an HMO in order to support the government in implementing and conducting 
the accreditation process within both public and private health facilities. 
Table 3: Accreditation categories for hospital assessment 
(Source: Cleveland et al. 2011: 274) 
6.4 Nursing education accreditation 
A second example of a successful accreditation scheme is in South Africa, which imple-
mented an institutional accreditation of nursing education. In the context of South Africa, 
only institutions and educational programmes accredited by the Nursing Education and 
Training Quality Assurance are legally allowed to provide education or training to qualify a 
nurse (Mtshali et al. 2019: 92). Mtshali et al. (2019: 93) conducted a qualitative study with 
heads of nursing education institutions to examine potential benefits from the accreditation 
scheme. These benefits were categorised into four themes, namely: a) institutional benefits, 
b) nursing educators’ benefits, c) students’ benefits and d) nursing education benefits. 
When summing up the specified benefits from the different categories, it can be said that 




best practice and networking opportunities. Furthermore, the accreditation promoted stand-
ardisation, effectiveness, and quality in regard to teaching and learning. It also enabled the 
educators to assess performance compared to set performance standards and work further 
towards their improvement. Accreditation not only benefitted the institution and the educa-
tors, but also the students, as their prestige increased and created a higher demand of 
graduates in the workplace (Mtshali et al. 2019: 93 ff.). As in many West African countries, 
nurses are usually the first point of care on a primary level of health provision in Côte 
d’Ivoire. However, there is a major lack of data regarding the qualification and distribution 
of health personnel, especially in the private sector (Duran et al. 2020: 43). A functioning 
accreditation scheme, such as the example from South Africa, could allow an HMO to im-
prove data availability, ensure standardised quality treatment, and set further standards for 
both the public and private sector. 
6.5 HMO relevance 
In general, HMOs can take over several different types of functions in regard to an accred-
itation scheme. Depending on the current state of an accreditation system – for example if 
none exists yet – an HMO can promote and advocate the necessity of developing and im-
plementing such a scheme for the above-mentioned reasons. An HMO can also act as an 
accreditation body itself, assigning certificates to eligible healthcare institutions. Alternately, 
it can either directly manage a healthcare institution seeking to acquire an accreditation 
certificate itself or help such an institution by providing technical and financial support during 
the accreditation process (UNIDO 2017: 16 ff.). 
In conclusion, it is clear to say that working accreditation systems have apparent benefits, 
as demonstrated above. However, there are always certain challenges in the process of 
planning, implementing, and sustaining such a scheme. These include limited available re-
sources to implement and sustain such a project (Mansour et al. 2020: 12). Further hinder-
ing factors which have to be taken into account are the given political situations, such as 
that in Côte d’Ivoire. Shaped by two civil wars and inconsistent government and policies, 
this could lead to insufficient commitment for the programme. This goes hand in hand with 
other issues on a governmental level such as policymakers’ specific interests, which are not 
always in line with potential health benefits, and corruption (Mansour et al. 2020: 12). Other 
hindering factors, summed up as application factors, include poor available hospital infra-
structure, lack of technology, inadequately trained hospital staff and a general lacking com-






➢ HMOs can interact with stakeholders of different areas and levels to establish an 
accreditation system. 
➢ An HMO can seek to improve performance quality of healthcare by supporting the 
establishment of an accreditation scheme. 
➢ The political and social conditions must be considered by the HMO in order to 
effectively implement an accreditation system. 
➢ An HMO must take limited resources into account, resulting from general scarcity 
or critical circumstances. 
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7 Service availability and readiness 
Reliable information on service availability and readiness is necessary for successful health 
systems management. This is because it can allow health systems to be tracked, in terms 
of how they have responded to changed inputs and processes, and whether these changes 
have improved health outcomes or not (WHO 2013: 7). This chapter will provide a basic 
overview of what would need to be considered in terms of availability and readiness when 
setting up an HMO, taking into account the impact that access can have. Examples from 
Côte d’Ivoire will be used to illustrate this.  
7.1 Access 
When talking about the dimensions of service availability and readiness, it is important to 
additionally keep service access in mind. Service access includes a number of components: 
availability, which refers to physical presence of health facilities or workers; accessibility, 
which refers to how easily a patient can reach a provider's location; affordability, which re-
fers to the ability of patients to be able to pay for a service; and acceptability, which refers 
to the sociocultural dimension (WHO 2013: 9). It is important for an HMO to take each of 
these components into account, as just because a service is available or ready, does not 
mean that people will be able to access it (McLaughlin/Wyszewianski 2002). For example, 
when it comes to accessibility, geographic barriers and travel time would need to be con-
sidered in addition to the general availability of a facility. 
7.2 Service Availability and Readiness Assessment (SARA)  
When it comes to addressing the issues of service readiness and availability, there are 
many different frameworks that can be used to measure these dimensions. One of the most 
well-known frameworks for doing this is the Service Availability and Readiness Assessment 
– a comprehensive tool jointly developed by the WHO and United Nations Agency for Inter-
national Development. It offers a standardised approach to monitoring the supply of health 
services by providing a standard set of tracer indicators that can be applied to any health 
system (WHO 2013). The authors propose using the SARA for assessing service availability 
and readiness in regard to the implementation of an HMO, as it provides a useful monitoring 
tool that can be used to establish an overview of the HMO’s health facilities. 
7.2.1 Methodology  
The SARA provides the tool for the assessing service readiness and availability. In regard 
to availability, an important foundation for the SARA is having a Master Facility List (MFL) 
available – this is a list of all health facilities in a country, ideally up-to-date and complete, 
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which helps provide data on the availability of services (WHO 2017b). Figure 7 demon-
strates the methodology of what is required for a SARA. Ideally, a facility census of all facil-
ities should be carried out every 5 years on a government level (as depicted by the orange 
section), in addition to updates from different districts more regularly (blue section). In terms 
of service readiness (green section), the SARA usually selects a sample of all facilities 
stratified across all different types – both public and private – on which to carry out a more 
detailed assessment on. However, depending on the reliability of regular facility censuses 
on a national level, the HMO could play a role in carrying out facility assessments in coop-
eration with the MoH. In general, something to be considered when carrying out assess-
ments such as this, is that they can be combined with assessments from other dimensions 
e.g., in relation to quality or accreditation – to make it more efficient and to prevent wasting 
the HMO’s resources. 
Figure 7: Timeline of implementation for SARA 
 
(Source: WHO 2013: 15) 
7.2.2 Service availability  
Service availability refers to the physical presence of items required for the delivery of ser-
vices (WHO 2013: 12). It encompasses several domains, including health infrastructure and 
health workforce. For each domain the HMO would measure several items as tracer items, 
for example the number of available health facilities, beds or health workers.  
Côte d’Ivoire generally demonstrates a low level of service availability. For example, in the 
domain of health workforce, the national average of doctors per 10,000 inhabitants is low 
at 1.4 (Figure 8, orange bar), and there are also major problems in terms of distribution. 
Most doctors are concentrated in urban areas of Abidjan, whereas the majority of other 
regions have much fewer workers. Côte d’Ivoire currently has a new human resources strat-
egy in place, in line with work from the Human Resources for Health in 2030 (HRH2030) – 
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which aims to improve the training output of health workforce. The ongoing human re-
sources challenge within an HMO will remain in balancing the numbers between rural and 
urban areas, as well as preventing brain-drain to other countries.  
Figure 8: Doctors per 10,000 in Côte d’Ivoire 
 
(Source: Own presentation after Duran et al. 2020: 33)  
7.2.3 Service readiness  
Service readiness is divided up into two broad categories – general service readiness and 
disease-specific readiness. These categories would make it easier for an HMO to differen-
tiate and categorise different types of services, for example in regard to what might be in-
cluded in the benefit package (see Chapter 8). 
The SARA includes four broad categories for general service readiness – basic amenities 
and equipment, standard precautions, laboratory testing capacity and essential medicines. 
A certain amount of tracer items is set for each of these categories, which are considered 
necessary in order for a health facility to be generally ready, and can be taken into account 
when planning the service coverage of the HMO (Table 4). The average scores in Côte 
d’Ivoire for each of the general readiness categories ranged between moderate to high 
readiness overall for the category of standard precautions for example, at just over 80%, to 
very low readiness in terms of essential medicines (28%). 
Table 4: General service readiness 
Category Tracer Items examples 
Côte d'Ivoire Aver-
age Score (% of fa-
cilities) 




Amenities (7 items):    
• Water source within 500 m of facility  
• Room with auditory and visual privacy   
• Adequate sanitation facilities  
• Communication equipment (phone/short-wave radio)   
• Emergency transportation  
57% 
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Equipment (7 items):    
• Weighing scales  
• Thermometer   





• Safe final disposal of sharps/ infectious wastes  
• Disinfectant  
• Single-use disposable or auto- disposable syringes  
• Soap and running water or alcohol-based hand rub  






• Blood haemoglobin  
• Blood glucose  
• Blood smear or rapid test for malaria parasites (for 
countries where malaria is endemic)  
• Urine dipstick glucose  





• Amoxicillin  
• Atenolol  
• Ciprofloxacin  
• Paracetamol suspension  
28% 
(Source: Own presentation after O’Neill 2013: 924f)  
For service-specific readiness, the SARA sets out 20 key programme areas that provide 
different kinds of interventions related to different target groups, including for example im-
munisation, family planning and malaria treatment. It also sets out four domains, namely: 
staff and guidelines, equipment, diagnostics, and medicines and commodities. As with the 
general readiness, these programme areas and domains would be useful for an HMO in 
order to determine which services are necessary to include within the benefit package. Ta-
ble 5 shows an example for antenatal care services, and also specifies several tracer items 
that should be available within each domain. Here, the average scores for health facilities 
in Côte d’Ivoire also differ a lot – whilst medicines and commodities are widely available in 
this case, other items such as haemoglobin or protein urea test have low scores.  








Domains Inputs Côte d'Ivoire 
Staff and 
guidelines 
• Guidelines on antenatal care   
• Staff trained in antenatal 
care   
• 36% had directives availa-
ble   
• 45 % of staff trained ANC  
Equipment • Blood pressure apparatus    • No information   
Diagnostics 
• Haemoglobin test   
• Urine dipstick protein test   
• 12% haemoglobin test  
• 36% protein urea test  
Medicines and 
commodities 
• Iron tablets   
• Folic acid tablets   
• Tetanus toxoid vaccine    
• Commodities mostly avail-
able  
(Source: Own presentation after O’Neill 2013: 924 f.; Duran et al. 2020: 35 f.)  




Using the SARA in order to assess service availability and readiness has many potential 
benefits for an HMO. These include providing accurate information on the supply of health 
services, as well as providing a framework for monitoring these services. This standardised 
monitoring and review platform has the potential to improve the availability and use of data 
to inform health sector review processes on a global level (WHO 2015).  
Despite these potential benefits, existing or potential challenges in regard to service avail-
ability and readiness must also be taken into account when setting up an HMO concept. 
Firstly, although the SARA is a very comprehensive assessment tool, it does not assess all 
aspects that need to be considered. For example, although it looks at availability, one facet 
of access, it does not actually address other dimensions of access such as geographic 
barriers, travel time and affordability. Secondly, the SARA assesses readiness and availa-
bility - which are considered prerequisites for quality – but it does not directly address any 
quality indicators. Therefore, the HMO would need to combat these challenges by extending 
the assessment tool to make it more comprehensive or by carrying out further assessments 
to address other dimensions such as access and quality. 
The SARA has demonstrated where further work is required and which weaknesses are 
present in the Côte d’Ivoire’s system, which would need to be considered during the plan-
ning and implementation of an HMO. This would include addressing factors such as distri-
bution of human resources, ensuring access for rural populations, and improving availability 
and readiness particularly regarding diagnostics and medicines. The burden of disease also 
needs to be taken into account, in order to ensure that priority diseases are reflected in the 
services an HMO provides. 
Key messages: 
➢ Reliable information on service availability and readiness is necessary for suc-
cessful health systems management as it allows health systems to be tracked, in 
terms of how they have responded to changed inputs and processes. 
➢ The SARA is a useful tool for an HMO as it offers a standardised approach to 
monitoring the supply of services by providing a standard set of tracer indicators. 
➢ The SARA can be combined with other assessments e.g., in relation to quality, to 
make it more efficient and to prevent wasting the HMO’s resources. 
➢ A factor that can hinder the reliable assessment of service availability and readi-
ness by an HMO is the lack of a complete and up-to-date MFL. 
➢ Issues particularly affecting the West African region in regard to availability and 
readiness that an HMO must take into account include the unequal distribution of 
human resources, inequitable access for rural populations, and low availability 
and readiness particularly regarding diagnostics and medicines. 
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8 Designing a health benefit package  
A health benefit package (HBP) can be defined as “the set of health services and products 
that can feasibly be financed and provided for everyone, given a particular country’s [or in 
this case HMO’s] actual circumstances” (Glassman et al. 2017: 1). Besides limitations 
deriving from available funds, other aspects such as infrastructure, culture or human 
resources also constrain the range of services that can be offered by an HMO. Therefore, 
tough choices must be made during the design of the HBP, in a transparent way, in order 
to weight the claims of patients, localities, services, and technology suppliers (Glassmann 
et al. 2017: 3 ff.). This chapter aims to elaborate on important considerations in the design 
of a HBP for an HMO, using the example of Sierra Leone. 
8.1 Roadmap to an HBP for an HMO in Sierra Leone 
Figure 9 shows a model comprising ten core elements of a HBP design, which was 
introduced by Glassman et al. in 2017. It is probable that the sequential order of the different 
elements presented in this model will not be reflected in reality, as actors likely face the 
challenge of having to work on several elements at the same time. Nevertheless, it helps to 
illustrate both the interdependence of the different features as well as the continuous 
process a HBP design requires (Glassman et al. 2017: 7 f.). The model represents the basis 
for a roadmap to a HBP for an HMO in Sierra Leone, which will be presented in the following 
sections.  
Figure 9: The ten core elements of a HBP design after Glassmann et al. 2017 
 
(Source: Glassman et al. 2017: 8) 
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To begin, the authors clearly defined the intended impact of the HBP. The aim of this HMO 
is to provide a range of services complementary to already existing health services and thus 
to provide its beneficiaries with a HBP that covers unmet health needs and maximally 
benefits its members. Each of the following steps must be in line with this defined goal to 
ensure coherence. This includes the setting of non-technical criteria for the inclusion and 
exclusion of disease control priorities. The authors decided to use the burden of disease as 
basic selection criteria. Additionally, service inclusion and exclusion criteria within the 
disease control priorities were agreed upon. Following the goal to provide a complementary 
HBP, services already covered by other public institutions were defined as not eligible for 
inclusion in the roadmap. The same also applied for interventions that were considered 
ineffective. In line with this, the decisions of well-known assessment agencies would be 
used initially, in order to reduce labour and costs for the HMO. Implementing an integrated 
assessment agency could be considered as a long-term goal, that might be pursued when 
more financial resources are available (cf. Glassman et al. 2017: 8 ff.).  
Next, non-technical criteria were transferred into specific technical criteria to reach a 
defendable appraisal method for the inclusion or exclusion of services into the HBP (cf. 
Glassman et al. 2017: 9). The WHO recommends using disability-adjusted-life-years 
(DALYs) to assess the overall burden of disease (WHO 2021c), which is why this indicator 
was also used for the further design of the HBP. The selection of an appraisal method is 
closely linked to the previously defined goal. In line with the objective of the HBP, a cost-
effectiveness analysis was selected as the appropriate method of operationalisation (cf. 
Glassman et al. 2017: 9).   
Table 6 demonstrates the disease categorisation and prioritisation that was carried out 
during the design of this roadmap for the HBP design. The authors agreed on six service 
categories, namely preventative care services, primary care services, mother and child 
health care services, mental health care services, secondary and tertiary care services as 
well as emergency care services. Within the respective service categories, diseases and 
their possible interventions were ranked according to the number of DALYs they generated, 
to create a triage. High-ranking services were given high priority, whereas the inclusion of 
lower-ranking services was considered a mid-term or long-term goal of the HBP. In the case 
of preventative care services, the authors agreed to weight NCDs and communicable 
diseases (CDs) equally by ranking them alternately. In regard to emergency care services, 
no triage system was created as an equal level of disease severity was assumed. (cf. 
Glassman et al. 2017: 9 f.).  
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DALYs=Disability-adjusted life-years, CD= Communicable disease; NCD= Non-communicable disease 
(Source: Own presentation) 
In order to reach a transparent inclusion process, the Service Inclusion Protocol, presented 
in Table 7, was designed. It comprises several core elements of a HBP design, starting with 
the collection and collation of evidence. In regard to possible interventions, guidelines from 
different assessment agencies on treatment options for the respective disease must be 
screened, as well as further literature if necessary. Next, the protocol requires reflections 
on the costs of the different possibilities for treatment. As a first step this involves a cost-
effectiveness analysis (CEA). In this context it must be pointed out that CEA cannot be 
easily transferred from one health care system to another, which is why decision-makers 
must accept possible trade-offs in regard to this methodologic choice. As a further step, 
actors must calculate if the proposed changes are affordable by undertaking a budget 
impact assessment. This step is especially important to ensure the sustainability of the 
resulting HBP. Next, the collected data must be discussed and put into perspective. This 
allows relevant considerations to be added upon, that were not previously discussed, but 
are important for the final inclusion decision (e.g., limitations in infrastructure or training of 
health care professionals).  The aim of this process is to reach a final recommendation on 
services to be included in the HBP. This conclusion is final until the next round of the HBP 
evaluation and must be binding for decision-making (cf. Glassman et al 2017: 10 ff.). 
Examples of Service Inclusion Protocols can be retrieved from Appendix 3 “Service 
inclusion protocol examples”.  
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Table 7: Service Inclusion Protocol 
  Deliberation   
Disease  Name (Service category)   
Prevalence / incidence (year) 
Possible  
Interventions   
1. Intervention  
2. Intervention  
etc. 
Evidence   Evidence resulting from scanning recommendations from other relevant institutions and 
further literature   
Costs  
(All presented prices 
are approximations 
and do not reflect re-
ality)   
Cost-Effectiveness Analysis (CAE):   
1. CAE for first intervention 
2. CAE for second intervention 
etc. 
 
Budget Impact Assessment  
→ Available remaining budget for service categorya): 
  
1. Budget impact assessment for first intervention 
 
      Annual intervention costsb) x Estimated number of members in need  
             of treatmentc):  
      → 90 % / 95 % / 100 %d):  
 
2. Budget impact assessment for second intervention  
 
          Annual intervention costsb) x Estimated number of members in need  
             of treatmentc):  
      → 90 % / 95 % / 100%d):  
etc. 
 
Discussion  Further constraints that must be considered (e.g., in infrastructure or culture) 
Recommended ser-
vice for  
inclusion  
→ First line treatment   
(→ Second line treatmente))  
(Long term goalsf))  
Comments:   
a) Available remaining budget for service category= Total budget for service Category- Estimated expanses for already cov-
ered services within the respective service category  
b) Estimated costs for the annual costs of drugs derive from the International Medical Products Price Guide (IMPPG). For the 
estimated appointment costs with health care workers, an hourly salary of US$ 0,70 was assumed, based on the average 
monthly salary of USD$ 110 for nurses employed by the Ministry of Health (Ministry of Health and Sanitation 2016: 38) and 
under the assumption nurses work 40 hours per week   
c) Assuming 10 % population coverage and no differences in the prevalence/incidence of the respective condition in the group 
of beneficiaries compared with the total population  
d) The proportion used to calculate price coverage by the HMO (90 % for secondary/tertiary care services; 95 % for primary 
care services, mother & child care services, mental health care services; 100 % for preventative care services) 
e) Second line treatment options can be used if no results can be seen with a first line treatment option   
f) Broader investments that have the potential to reduce costs and should be pursued  
(Source: Own presentation)  
When it comes to the allocation of resources within the HBP, this roadmap recommends 
that the HMO put regulations in place to ensure the inclusion decisions that have been taken 
are reflected in its resource allocation. Additionally, the HBP should constantly be adjusted 
to the available resources (cf. Glassman et al. 2017: 11 f.) After the HBP has been 
introduced, it becomes important to monitor its performance in order to guarantee its 
financial sustainability. Therefore, prescription and utilisation data must be constantly 
collected. This enables the HMO to monitor whether services have really been delivered, 
and to make important adjustments and enable negotiations on prices with manufacturers 
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(cf. Glassman et al. 2017: 12). This information will also support the permanent revision of 
the HBP. In addition, data on new technologies, as well as new evidence, regarding 
included services should be taken into account during the evaluation of the HBP together 
with changes in the available resources (cf. Glassman et al 2017: 12). A potential model for 
a revision time frame would include periodical small evaluations after one year, medium 
evaluations after five years and extensive evaluations every ten years. This allows short-
term, mid-term and long-term goals to be set for the HBP and enables decision-makers to 
undertake adjustments accordingly during the same time frame.  
8.2 Coinsurance model  
This section aims to illustrate how treatment costs are shared between the HMO and its 
members. The patient coverage proposed by this HBP is limited to a certain proportion of 
the treatment costs, a model which is called coinsurance, where the remaining proportion 
of the costs is paid by the patient themselves (Mayo Clinic 2020). In practice, the percentage 
that must be paid out-of-pocket by the patient, would range from no OOPs for preventive 
care services; to 10 % for primary care services, maternal and child health care services 
and mental health care services; and 20 % for secondary and tertiary care services. OOPs 
for emergency care services would be made according to the care level delivering the 
according treatment.  
It is well known that cost-sharing arrangements have the potential to disproportionately 
burden poorer and chronically ill population groups, which can prevent patients from 
seeking the care they need (Krubiner/Faden 2017: 299). To counteract these observations, 
Table 8 presents an annual upper ceiling (AUC) for OOPs that should be introduced by the 
HMO in regard to the HBP. This threshold was calculated as a percentage, ranging from 5 
% to 25 % of catastrophic health expenditure (CHE) for each of the five income quantiles in 
Sierra Leone. CHE is defined here as annual health care costs, that exceed 40% of the 
annual household income after subsistence needs have been met (Xu et al. 2003). For 
subsistence needs an annual lumpsum of US$ 1240 was assigned per household, based 
on consumption expenditure data in Sierra Leone from an integrated household survey in 
2018 (Statistics Sierra Leone 2019: 201 ff.)  The following formula presents the AUC for 
OOPs:  
AUC for OOPs = (Annual average income – US$ 1240) x 0.40 x percentage of CHE 
As CHE for the first income quantile ranged below zero (cf. Table 8) a different approach 
for calculating the AUC for OOPs was taken for this quantile. In this specific case, as a 
substitute, 50 % of the AUC for OOPs from the second income quantile was used.  
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income (in US$) 
Catastrophic health 




Annual upper ceiling 
for OOPs (in US$) 
1. 289 <0 5  0.20 
2. 1250 4 10 0.40 
3. 2860  650 15 100 
4. 6150 1,960 20 390 
5. 26,820 10,230 25 2,560 
(Source: Own calculation after Statistics Sierra Leone 2019: 191, 201) 
In addition, certain services, as well as population groups, would be exempted from OOPs. 
Payments by the patient would not be required for primary care services, maternal and child 
health care services and mental health care services if the patient is referred for treatment 
by another provider (e.g., referral from preventative care services to primary care services). 
In case a treatment can only be delivered in more than one interaction, OOPs must only be 
made for the first appointment and no further payments would be required for follow-up 
appointments. Finally, it was decided to completely exclude birth deliveries from OOPs. 
Also, for children under five years and elderly over 65 years, all services would be 
completely covered. It is important to note that this list of excluded services and population 
groups cannot be considered final. Instead, the authors recommend using an approach 
from Cambodia as inspiration, where community leaders were asked to decide on who 
should be exempted from user fees (WHO 2010: 45). A similar approach could help to 
enable the participation of members in the decision-making processes of the HMO and to 
create more equity and transparency.  
8.3 Actuarial calculations   
In this section, the results of three steps of the actuarial calculations for Sierra Leone will 
be presented, namely demographic projections, revenue projections and a benefit cost es-
timation. The underlying actuarial calculations are presented in Appendix 2 “Actuarial cal-
culations – Sierra Leone”. Undertaking such calculations is beneficial when designing a 
HBP as they can estimate the available resources and how they can be used efficiently for 
covering certain services.  
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8.3.1 Demographic projections 
This section illustrates Sierra Leone’s population projection and how it will develop within 
the next years, in order to facilitate the calculation of the revenue produced and the estima-
tion of projected costs.  
Figure 10: Total population projection Sierra Leone 
 
(Source: Own presentation after Togoh et al. 2017: 4, 19)  
Figure 10 shows a continuous increase in the total population with an estimated growth rate 
of around 2.5 % yearly (Togoh et al. 2017: 4 ff.). Population growth provides an insight into 
how the population’s size and age range is changing, which is important for calculating the 
size of the working groups that will pay contributions. The population projections by age 
groups (Figure 11) gives an approximation of the relation between the population group and 
the utilisation of services. For instance, 40 % are under 15 years old which suggests that 
childcare services are greatly needed, meaning this should be taken into consideration in 
the HBP design. 
Figure 11: Population projection by age group Sierra Leone 
 
(Source: Own presentation after World Bank 2020 f.) 
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8.3.2 Revenue projections 
Calculations in regard to revenue projections are based on the assumption that the HMO 
would provide coverage for at least 10 % of Sierra Leone’s population. This membership 
rate was set in order to ensure enough revenue can be generated for the HMO to function. 
60 % of the revenue projected will flow into designing the HBP, as this includes all services 
as well as provider payment. 
Four types of sources were identified for revenue collection in Sierra Leone, namely: con-
tributions from both the formal and informal sectors; external governmental resources; and 
external non-governmental resources (see Appendix 2). The formal sector is estimated to 
include 30 % of the working population, while the informal sector includes 70 %. From both 
sectors, a contribution rate of 6 % would be collected, which is based on calculations by the 
Ministry of Health and Sanitation (MoHS) in Sierra Leone (Ministry of Health and Sanitation 
2017: 55). In the case of the informal sector, the willingness to pay would be taken into 
consideration, and divided into five income quantiles to ensure equitable financing. Five 
percent of the budget allocated to the MoHS would flow to the HMO’s revenue, seeing as 
the HMO is part of Sierra Leone’s healthcare system and would offer many health services 
that are not provided in the public sector, which in turn is important for the health and 
productivity of the population. In this way, the HMO would not only be able to gain more 
revenue, but also collaborate with the country’s healthcare system directly. 
External non-governmental resources would be collected to coordinate the design of the 
HBP of the HMO with the external funds and vertical programmes available in Sierra Leone. 
Sierra Leone receives around 274 million leones (US$ 2.6 million) of external funds towards 
the MoHS budget, for financing different vertical projects (Saffa 2020). Generally, ear-
marked donor funds and vertical programmes are not included in a HBP design in LMICs. 
However, establishing one single pool to join together different funds as a budgetary support 
for the HBP can be helpful in increasing the availability of different resources which can be 
used efficiently and include more services and projects to empower the health system of 
the country. Ethiopia and Rwanda have succeeded in implementing this theory (Glassman 
2017: 90 ff.). Therefore, this HMO would aim to coordinate with existing vertical pro-
grammes and donor funds and include these funds within revenue collection and the HBP 
design. 
To ensure revenue collection, different approaches to avoid risk sharing challenges should 
be considered during the enrolment process.   
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8.3.3 Benefit cost estimation 
The benefit package would be designed according to the available resources, as demon-
strated in Table 9 for the years 2021-2023 in Sierra Leone. The yearly revenue would be 
allocated by percentage to the six service categories introduced in the first section. The 
percentage of budget coverage would differ according to which care package is necessary 
and needed by the enrolees, and would set an upper threshold according to which interven-
tions would be added. 20 % of the budget would be allocated to the following service cate-
gories: preventive care; primary health care; maternal and child health care; and secondary 
and tertiary health care. 10 % of the budget would go to mental health care and emergency 
care.  
Table 9: Summary of revenue projection and budget allocation (million US$) 
 2021 2022 2023 
Total revenue projection 212 219 228 
Total revenue projection for benefit package: 
 
20% Budget allocated to each category (total 80%) 
- preventive care 
- primary health care 
- maternal and child health care 
- secondary and tertiary health care  
 
10% Budget allocated to each category (total 20%) 
- mental health care 
- emergency care 
















 (Source: Own presentation after Statistics Sierra Leone 2019: 191, 201; Saffa 2020) 
Table 9 demonstrates the amount of the budget allocated to the different service categories, 
with each having been assigned either 20 % or 10 % of the yearly budget.  
Next, the previously designed list of disease control priorities (cf. Chapter 8.1) for each 
service category must be applied. For each disease included in the service, interventions 
with highest evidence and cost-effectiveness would continue to be added until the upper 
ceiling of the budget has been reached. Importantly, the calculations of intervention costs 
would be carried out according to the previously mentioned coinsurance model, as well as 
the budget impact analysis. For instance, the estimate of preventive care costs would be 
calculated at 100 % because no coinsurance is to be paid for this type of care. However, 
for secondary and tertiary care, 80 % of costs are to be covered by the HMO and 20 % by 
coinsurance from members; therefore, the estimated costs would be calculated at 90 % in 
order to take into account the costs of those exempted from paying coinsurance. Similarly, 
instead of calculating 90 % coverage of primary care, maternal and childcare as well as 
mental health care, estimated costs would be calculated at 95 %. The different steps of the 
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intervention inclusion process are demonstrated with diseases relevant to Sierra Leone in 
Appendix 3 “Service inclusion protocol examples”.  
8.4 Cost control through utilisation management  
Utilisation management can be defined as “a diverse set of activities designed to influence 
the use of health care services and thereby constrain health care resource consumption” 
(Wickizer/Lessler 2002: 233). As a first step towards the utilisation management of this 
HMO, the services for which insured members would not receive coverage must be clearly 
defined. As previously explained, it was initially agreed upon to exclude from coverage 
services already covered by other public institutions and treatments that have been 
declared as ineffective by assessment agencies. In addition to this, Figure 12 presents 
which other services would not be covered by the HMO.  
Figure 12: Health services excluded from coverage 
(Source: Own presentation) 
Another important measure in utilisation management for an HMO is the implementation of 
a referral system that uses lower levels of care as gatekeepers for the secondary and 
tertiary care levels and requires members to present a referral from another provider to 
receive service coverage for these specific services. Such a system has shown to be helpful 
in containing health care costs by limiting appointments with specialists (Martin et al. 1990: 
1632). Nevertheless, one needs to recognise that in emergency care it would not be feasible 
to obtain a referral from another provider before receiving secondary or tertiary care.  
Recognising this problem, the authors recommend implementing an emergency referral 
phone number for patients. Members that are in need of urgent care can call this number 
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and receive recommendations by trained health care workers in regard to the appropriate 
provider for their health problem. In this case, a recommendation for secondary or tertiary 
care by this number will suffice as a referral. Similar models have been previously adopted 
elsewhere and have proved to be economical (Simone 2009: 5 f.). In these particular cases, 
patients would receive their usual 80 % coverage of secondary and tertiary care, without a 
prior referral.  
The previously introduced coinsurance model is also another measure used within 
utilisation management. Including patients in their treatment costs, even with a small 
proportion, has proven to be effective in changing the behaviour of patients (Simone 2009: 
11). In addition, the detailed design of the coinsurance model has the potential to help 
contain health care costs. As the OOPs proportion increases with the rising level of care, 
one can assume that the utilisation of lower care levels, for example for preventative or 
primary care, would be incentivised in comparison with secondary and tertiary care 
services.  
Finally, billing data, as well as data from quality management should be used to monitor the 
utilisation of services by the patients. This information helps to determine necessary 
changes in the HBP design during the periodical revision of the HBP.  
Key messages: 
➢ Models, such as the one introduced by Glassmann et al., help to enable discus-
sions on the most relevant aspects in designing a HBP for an HMO. 
➢ Reality will differ from assumptions based on a model, meaning an HMO needs 
to constantly monitor the HBP, as well as the service utilisation, to determine nec-
essary changes. 
➢ HBP design and implementation are determined by the availability of resources 
and how efficiently they are allocated as well as the disease burden within the 
population. 
➢ The authors propose including a coinsurance scheme within the HBP design, 
which will affect the service utilisation of members. To prevent an extreme finan-
cial burden on households, an AUC for these expenses has been defined for each 
income quantile.  
➢ Services excluded by the HMO must be clearly defined a priori and should include, 
amongst others, unnecessary or ineffective medical treatments. 
➢ Different measures, such as a referral system or the gatekeeper principal, help to 







9 Pharmaceuticals  
People spend a significant share of their income on medicines, and the share of govern-
ments’ health expenditure invested in pharmaceuticals is also large. Countries must try to 
make medical products available, affordable and accessible, to their whole population. They 
must also ensure that the products are safely stored and transported to everyone in need 
(Skolnik 2015: 127). This chapter describes which steps an HMO must consider when man-
aging a pharmaceutical supply chain. Additionally, practical examples of how the different 
steps can be implemented will be presented, using the example of Liberia.  
9.1 Essential drug prices, availability, and accessibility 
Medicines remain inaccessible, unaffordable, and not available for many West Africans. In 
2001, the WHO, together with Health Action International (HAI), established a standardised 
method to assess the availability, affordability, and medicine price components of essential 
medicines across countries (WHO/HAI 2008: 3). Data for several countries can be found on 
the HAI Database (HAI 2021). Among the countries assessed were four West African coun-
tries, namely: Ghana, Nigeria, Mali and Burkina Faso. In those countries, the mean availa-
bility of the lowest price generics in the public sector ranged from 17.9 % in Ghana to 81 % 
in Mali. The affordability of drugs in these countries can be analysed by comparing the wage 
of the lowest-paid unskilled government worker in relation to the treatment of diabetes for 
30 days. When purchased from the private sector, glibenclamide, a medicine used to treat 
diabetes, can cost the lowest-paid unskilled government worker up to 3 days wages (Nige-
ria) for the lowest price generics, and up to 12 days wages (Ghana) for the originator brand. 
When comparing the median price of a basket of five medicines, standardised to the Man-
agement of Sciences for Health reference price, the average median price ratio (MPR) was 
lowest in Mali, in both the public and private sector, with a MPR of 2.11 and 3.28, respec-
tively. In Nigeria, the median MPR was highest for the public sector and in Burkina Faso it 
was highest for the private sector with a MPR of more than 7, indicating that the local med-
icine price in the private sector is on average 7 times higher than the international reference 
price (HAI 2021). Unfortunately, the surveys of the West African countries were conducted 
between 2004 and 2009. No up-to-date data addressing the availability, affordability, and 
prices of essential drugs in West African countries could be found. To properly evaluate the 
efforts made to reach the Sustainable Development Goal indicator 3.b “[…] provide access 
to affordable essential medicines and vaccines […]” (United Nations 2015: 19), further data 




9.2 Medicine supply chain management 
This section will present the theoretical considerations and the practical implementation of 
medicine supply chain management. The scheme below (Figure 13) illustrates the path from 
selecting essential medicines the HMO members require, to finally distributing them from 
the highest level of the supply chain to where they are needed. During this process, gov-
ernment regulations must be fulfilled, contracts closed, the quality of the medical products 
ensured, and up-to-date information collected to constantly improve the system.  
Figure 13: HMO medicine supply chain 
 
(Source: Own presentation) 
9.2.1 Selection 
To begin, the HMO needs to prioritise a list of medicines that will be prescribed by the HMO, 
which should reflect the medicines included in the HBP. This list also needs to match the 
financial resources available and should address the disease burden of the HMO’s mem-
bers (MoHSW 2010: 26). In the case of Liberia, the “2nd Edition National Standard Thera-
peutic Guidelines and Essential Medicines List Liberia” established by the MoH, can be 
used as an orientation to select medical products from. The medicines most needed by 
patients must be selected, whilst other cost-effective drugs can be added additionally. As 
85 % of medications on Liberia’s Essential Medicines List can be found on the WHO’s Es-




framework (Persaud et al. 2019: 404B). It is important for the HMO to work closely together 
with the governmental institutions that set provisions and restrictions, to fulfil all regulations 
when purchasing and distributing pharmaceuticals throughout the country. 
9.2.2 Quantification and forecasting 
The next step requires the demand for the selected medical products to be quantified and 
forecasted. Therefore, historical data of consumption must be obtained from health facilities 
and medical stores within Liberia, especially in the region where most HMO members come 
from. Additionally, epidemiological data of the country needs to be analysed to identify how 
many people suffer from which disease and trends such as the rise of specific diseases. 
Using these analyses, it can be estimated to which extent the patients will suffer from which 
diseases, allowing the demand for medical products for treatment to be forecasted. The 
prices of these medical products can then be calculated and compared with the available 
financial resources. Following this, a supply plan must be developed, which defines when 
the products need to be ordered, when they will arrive, how much needs to be procured, 
and how much they will cost. The overall goal is to organise a steady, uninterrupted, and 
sufficient supply of the medical products that patients require. This step requires regular 
evaluation and data analysis to adapt the supply plan (SIAPS Program 2014a: 3). There-
fore, the HMO should use technology that records data, helping its management to set up 
contracts with manufacturers that match the health needs of HMO members. 
9.2.3 Procurement 
The third step is the procurement of medical products. Managing the tendering, bidding, 
and contracting process is the main focus of this stage, which benefits from well-defined 
and accountable proceedings. To proceed successfully, explicit criteria for procurement de-
cisions need to be set to ensure transparency and a fair process. Manufacturers of high-
quality medical products that are cost-effective, and reliable suppliers, should then be se-
lected (SIAPS Program 2014b: 4). To prevent high dependency on one specific supplier, 
contracts need to be closed with various manufacturers. However, it must be noted that it 
is important to balance out the number of manufacturers from which the HMO can buy and 
still get quantity discounts, so the products remain affordable. Currently, it may be neces-
sary to work closely together with different foreign manufacturers, as drug manufacturing in 
Liberia or even West Africa is scarce (Ekeigwe 2019: 2). In addition, a management infor-
mation system needs to be established to track the status of orders and payments, as well 





As a fourth step, the newly arrived medical products need to be received and stored in a 
suitably located warehouse. The inventory needs to be managed and documented, to en-
sure a constant flow of medical products in a cost-effective and timely manner, and in the 
required quantities. Qualified human resources are also needed to allow the receiving, stor-
ing, and dispatching operations to be managed smoothly. In addition, performance moni-
toring is required, and the warehouse should have appropriate storage installations availa-
ble where good practice storage solutions are followed (SIAPS Program 2014c: 3). In the 
case of Liberia, the warehouse would be located in or around Monrovia, the capital of Liberia 
and located in the Montserrado district; the most populous region in Liberia and therefore a 
good place to establish an HMO, as it depends on the inclusion of a large group of people 
to work efficiently (LISGIS 2009: 10). From there, medications can be delivered to pharma-
cies and health care facilities the HMO cooperates with. Moreover, the warehouse is the 
first stage of a threefold drug quality check. Firstly, it must be equipped with laboratory and 
personnel that randomly inspect the efficacy and safety of imported medical products. In 
addition, the HMO would implement a second step to ensure the quality of its drugs by 
testing medicines in some of the bigger pharmacies and health care facilities with ‘minilabs’. 
Minilabs are suitcases including all important instruments to check the quality of various 
antibacterial medicines, antimalarial medicines, antimycobacterial medicines, antiretroviral 
medicines, anthelminthic medicines, other anti-infective and antiseptic medicines, and non-
anti-infective medicines (GPHF 2021a; GPHF 2021b). Pharmacies and health care facilities 
must be stocked with essential medicines at all times so that patients have access to them. 
Cooperation with existing pharmacies and health facilities is conceivable, but if an area is 
not sufficiently covered, the HMO would set up its own providers to ensure healthcare is in 
reach for all of its members. The third step of the drug quality check relates to distribution 
and it therefore discussed in 9.2.5. 
To prevent stockouts, the HMO would apply a short-message-service (SMS) system. A 
study carried out in Tanzania used a SMS system to avoid stockouts of malaria treatment. 
Following recommendations by Barrington et al. (2010), every pharmacy and health care 
facility cooperating with the HMO should therefore be supplied with a registered mobile 
phone number. A SMS message will regularly be sent to every registered mobile phone 
number, enquiring about stockouts. The facility can answer via the registered mobile phone 
number when medications are low in stock. If a facility does not reply within a certain time 
period, a reminder will automatically be sent to the registered mobile to give facilities a 




regarding stockouts to the warehouse, which can afterwards deliver the required medica-
tions. The study showed an increase of fully stocked facilities and a high SMS response 
rate of pharmacies and health care facilities (Barrington 2010: 2 ff.).  
9.2.5 Distribution 
In the final step of the medicine supply chain, the distribution of medical products is organ-
ised. The main goal is to ensure that medical products are safely distributed to those who 
need them, in a timely manner. During transportation, the products should always be trace-
able and stored in accordance with the conditions stated on the medicine labels, so that the 
safety and quality of the products are not put at risk (SIAPS Program 2014d: 3).  
Reaching rural areas may be a major distribution challenge. If members living rurally feel 
that the HMO is not adequately caring for them, they may decide to opt-out or never contract 
with the HMO. To prevent this, the HMO plans to cooperate with community-based health 
care volunteers, as they are more familiar and within reach of the people. The volunteers 
will be authorised to pick up drugs in pharmacies or health facilities and forward them to the 
patients. They will be trained by the HMO on how to administer medications properly and 
how to detect unusable or counterfeit drugs. Thus, they perform the third step of the three-
fold drug quality check. Researchers investigated the motivation of community-health care 
volunteers in Ghana and found that volunteers mentioned the desire to help, prestige and 
equipment with helpful materials such as bicycles and torch lights, as motivation and incen-
tive for volunteering (Chatio/Akweongo 2017: 5 ff.). Therefore, the authors recommend that 
the HMO should contribute to the willingness of volunteers by providing equipment. 
Figure 14: Medicine supply chain 
 















9.3  Performance improvement 
The whole process of medicine supply chain management should be evaluated and 
adapted regularly in order to be more efficient and to prevent errors such as overstocks or 
stockouts of products in the future. Therefore, during every step of the process, data must 
be collected from different actors. A free hotline will be installed to get direct feedback from 
patients or community-based health volunteers to find out whether they have received what 
was needed or if they have faced any stockouts. In return, the HMO-hotline would 
strengthen the patient’s knowledge of health by promoting the rational use of medical prod-
ucts. As the proper use of medical products is crucial, skilled health professionals such as 
doctors, nurses and pharmacists will provide information on health and on how to use a 
medication, if people cannot read or understand the instructions given on the medication 
package or package insert. The hotline could also advise on whether a visit to a health care 
facility is necessary if a patient is unsure about how to interpret their symptoms. Especially 
people living in rural areas will benefit from a hotline offering advice, as the direct visit of a 
health care practitioner may be too time-consuming for them. The implementation of the 
hotline would follow experiences made in Malawi in 2011, where a hotline was implemented, 
that answered questions on health and nutrition. The hotline initially started as a pilot pro-
ject, but later covered the whole country and reached high levels of trust and satisfaction 
among users (Blauvelt et al. 2018: 1 ff.). 
A further aspect of performance improvement includes the HMO collecting data on the med-
ical products consumed by its members, as well as the diseases they suffer from. This data 
can be used to forecast which medicines are needed so that the patients are not affected 
by stockouts. Additionally, the performance of the different stages can be assessed, to en-
sure the quality of medicines is maintained. In line with this, HMO members will have the 
opportunity to express complaints or report side-effects of medicines through a hotline. In 
addition, the HMO’s community-based health workers will record the medicines they are 
distributing in rural areas, regularly communicate their data to the warehouse, and docu-
ment any scepticism they face regarding the quality of drugs. Data in regards to falsified 
and counterfeit drugs detected at any point in the supply chain will also be documented and 
analysed regularly, to make informed decisions on potential adaptions, such as changing 
manufacturers. 
To take these factors into account, the HMO would establish a comprehensive and suitable 
data management platform with personnel specifically trained to collect and analyse rele-
vant data. Additionally, standard operating procedures would be developed to facilitate the 
adaption of the medicine supply chain management system. Through these interventions, 
the HMO’s supply chain management system can improve steadily, and errors can be elim-





➢ Important steps of the HMO’s medicine supply chain include selection, quantifica-
tion and forecasting, procurement, storage, and distribution of medical products.  
➢ It is important that the HMO collects data at all stages of its supply chain to be-
come more efficient and adapt to the needs of its members. 
➢ Medicines provided by the HMO must be safe, available, accessible and afforda-
ble at all times and for all members. Stockouts must be avoided, and community-
based health workers would be employed to ensure distribution to patients in rural 
areas. 
➢ Due to the scarcity of data regarding the availability, affordability, accessibility, 
and prices of medicines in West Africa, the HMO should support improvements 




10 Quality management 
10.1  Introduction 
There is no single definition for quality, as it always depends on a person’s point of view 
and their personal preferences (Bart 2020: 8 f.). However, “[…] quality can be defined as 
the degree to which health services for individuals and populations increase the likelihood 
of desired health outcomes and are consistent with the current professional knowledge” 
(Institute of Medicine 2002: 1). Quality management is therefore based on coordinated 
mechanisms for leading and steering organisations. This means that it addresses not only 
the evaluation and measurement of certain indicators, but also the planning and implemen-
tation processes which actively contribute to a certain level of quality (Bart 2020: 9 f.). There 
exist a number of limitations regarding quality management, including the inability to be able 
to measure everything, and its resource consuming nature. However, despite this, it is im-
portant to consider the ethical obligation to ensure patient safety and to adhere to certain 
standards, especially in a medical context. Other advantages of quality management in-
clude the potential to more efficiently use resources which is especially relevant in the con-
text of establishing an HMO in a LMIC (Bart 2020: 11 ff.). 
Figure 15: Plan for implementation of a quality management system 
(Source: Own presentation) 
Figure 15 demonstrates an implementation plan for a quality management system. Firstly, 
together with important stakeholders, the general and living situation of the people and their 
needs must be identified. Health goals and quality goals are subsequently based on these 
needs. If for example a health goal is “access to primary health care services for every 
enrolee”, a related quality goal might be “having a community health worker not more than 
ten kilometres from the home of every enrolee”. The last step, implementing a mission and 
vision, is important for providing a general orientation frame on how to act, even if the quality 
management system is not yet fully implemented. It should include information about the 





10.2  HMO quality framework  
Quality is a construct based on theoretical implications and is only explicable by approxi-
mation. Therefore, it is important to build a quality strategy on a quality model, which seeks 
to explain which aspects, and the way they differ, can influence and structure different qual-
ity dimensions (Hensen 2019: 25 ff.). The authors have used Donabedian’s three-step ap-
proach as an example, as it makes the indicators influencing quality very tangible, provides 
a lot of detail and is often used in the health care sector. Generally, the model suggests that 
all parts are dependent on one another and represent a prerequisite for the next step (Hen-
sen 2019: 34). In addition to this model, a quality management framework is an ongoing 
process, which means that quality is always being controlled and new measures are being 
taken.  
Table 10: Donabedian Framework for the HMO 
 Structure Process Outcome 
Function 
Deals with the structural pre-
requisites/inputs 
Focuses on health care de-
livery related processes 
Have the desired medical 
endpoints/surrogate param-
eters been met? 
Examples • Buildings 
• Equipment 
• Adequate staff 
• Benefit catalogue 
• Contracts 






• Drugs, remedies, 
aids 
• Efficiency 
• Patient safety 
• Referral system 







• Quality indicators 
• Patient satisfaction 
• Staff satisfaction 
• economic mainte-
nance 
• Meeting set goals 
• Health status 
(Source: Own presentation after Hensen 2019: 32 f.) 
The importance of participation: 
The participation of important stakeholders such as the MoH and staff is very im-
portant for the implementation of a quality management system. Stakeholder en-
gagement may lead to improved acceptance of new measures, that may need to be 
implemented in order to guarantee quality. The knowledge of important groups 
should also be included within the concept, to help push the HMO members towards 
better understanding and accepting certain measures and quality goals. In some 
countries, it might also be difficult to find out about national guidelines and stand-
ards, for example via the internet, which underlines the importance of the participa-




10.3  Structural quality 
As aspects related to structural quality (Figure 16) have been previously described in Chap-
ter 7, this chapter will focus on other quality dimensions such as process and outcome 
quality. 
Figure 16: Examples of structural quality in an HMO 
 
(Source: Own presentation) 
10.4  Process quality 
Process quality includes the quality delivered through heath care and all sub-and support 
processes. In Table 10 several examples of process quality are listed, some of which will 
be explained in further detail below. 
10.4.1 Patient safety  
One crucial part of quality management is patient safety. According to the WHO “[…] it aims 
to prevent and reduce risks, errors and harms that occur to patients during provision of 
health care” (World Health Assembly 2019). Requirements for this include safe infrastruc-
ture, safe medical devices, their use by skilled workforce, as well as informed patients (Par-
ker et al. 2015). 
Figure 17: Possible quality interventions and tools for patient safety 




Alongside other quality interventions, another important tool is taking risk management into 
account. This includes the detection and analysis of existing risks and ways to prevent or 
reduce them (Scobie et al. 2006). To measure the quality of patient safety it is necessary to 
not only report and document errors or failures but also to define benchmarks with the help 
of comparable indicators (e.g., that there has not been an error in more than X % of all 
surgeries) and a continuous control of the trend. It would be important for an HMO to imple-
ment a system with easy reporting, which is able to count reported events automatically. If 
negative trends occur, improvement possibilities should be identified by carrying out a de-
tailed analysis of all included actions, equipment etc.  
10.4.2 Efficiency 
Efficiency is another important aspect of process quality. It is defined as the maximum out-
put from available resources (OECD 2013). Simplified, it is the ratio of the input and the 
output. Inputs are relatively easy to measure and can be separated into labour and capital. 
Output is more difficult to define. One possibility is to separate between financial output or 
revenue, and the amount of care provided. An example for measuring provided care could 
be to count the outpatient visits or inpatients days (Cyclus et al. 2017). When both input and 
output have been defined, the efficiency can be determined. The most common ways for 
doing this are by using a ratio analysis and a data envelopment analysis, both of which have 
differing characteristics (Table 11). 
Table 11: Comparison of ratio analysis and data envelopment analysis 
Ratio analysis Data envelopment analysis 
▪ The input-output ratio for financial and 
physical variables are separated 
▪ Easy to compute 
▪ Low costs 
▪ Can handle multiple input and output varia-
bles 
▪ More time and cost intensive 
➔ Provides useful information on the detec-
tion of inefficiencies 
➔ Clear and precise evidence 
(Source: Own presentation after Hafidz et al. 2018) 
Due to scarce resources in African LMICs, the ratio analysis is more suitable as it requires 
less time, money, researchers, and expertise to carry out (Hafidz et al. 2018).  
A potential intervention to increase efficiency, depending on what needs to be improved, 
could be to reallocate staff. This is to ensure that every facility has an appropriate number 
of staff members to improve outreach activities, reduce financial and physical barriers or to 




10.4.3 Referral system 
The referral system plays a major part in the quality of an HMO, as it decides whether 
patients see the right service provider or if the practitioner has the right information available 
to them. Figure 18 demonstrates the duties of the referral system, whilst Figure 19 presents 
exemplary quality interventions and measurements that an HMO can implement or utilise. 
Figure 18: Overview of processes in the referral system 
(Source: Own presentation)  
 
 
Figure 19: Quality interventions and quality measurements in the referral system 
 




10.5 Outcome quality 
10.5.1 Quality indicators 
To measure outcome quality, it is necessary to identify indicators which reflect the perfor-
mance of the HMO. As mentioned previously, health indicators must be used carefully as 
they are often too broad to use in relation to the HMO and its performance. To therefore 
select quality indicators which reflect the HMO’s performance, one can use the OECD da-
tabase as orientation to identify indicators for quality of care. An indicator for quality care of 
mental health would be the suicide rate within 30 days following hospitalisation, whilst qual-
ity of care related to cancer could be measured using 5-year net survival after diagnosis 
(OECD 2019). The indicators must also be in line with the services offered by the HMO. To 
use quality indicators there is the need for comparable indicators and set goals. Overall, 
health indicators should give an idea about the overall performance and the eventual need 
for improvement. When health goals are far from being achieved, then perhaps the set goal 
was unrealistic and the goal itself needs to be adjusted. 
10.5.2 Patient satisfaction 
As another example, this paper focuses on patient satisfaction as it is a crucial part of quality 
care. It is not only important as patients are the target group of every HMO but also because 
higher satisfaction leads to better adherence (Batbaatar et al. 2017). In this section, an 
example for The Gambia was developed, to demonstrate what a patient feedback system 
could look like (Figure 20). The patient feedback system was developed with the help of a 
local (J. Sisawo, personal communication, 1st December 2020). As patient satisfaction is 
always dependent on expectations shaped by the culture and other circumstances, local 
stakeholders should always be included when developing standards.  
Figure 20: Overview of a patient feedback system in The Gambia 
 




Tools for examination should be analysed well before applying them in practice to prevent 
over- or under interpretation of the results. Furthermore, the questions asked must be easy 
to understand and address all crucial areas (Shirley et al. 2016). Problems that could occur 
in The Gambia would be that people would not let the inquirer know when they do not un-
derstand the question but simply answer something that seems suitable. Another problem 
is the low literacy rate in The Gambia. Therefore, buttons according to traffic light colours 
have been used in the authors’ example. The results would therefore not be detailed, but 
provide an overview in regard to overall satisfaction in a timely manner. As there are about 
140 mobile phones per 100 inhabitants in The Gambia, another opportunity would be to 
provide a survey that is accessible either via barcode or by SMS code, as many phones are 
still non-smartphones (The Worldfactbook 2021b). This would likely be used more by the 
younger generation, seeing as their literacy rate is higher (The Worldfactbook 2021b). To 
gain a deeper insight into patients’ experiences and satisfaction, comprehensive face-to-
face interviews would need to be carried out annually at the health care facilities. When 
interpreting results, goals should be set, for example that not more than 10% of people who 
pushed the button pressed the red one. The resulting data should be evaluated at regular 
intervals, and if necessary, issues improved.  
The authors also suggest the HMO implement a complaint management system that gives 
the patient the opportunity to give written or oral feedback. To make a complaint manage-
ment system work, there need to be automatic paths so that every complaint is received by 
the same division, who's responsibility it is to evaluate all objections that have been re-
ceived, decide if something must be changed, and if so, then what.   
Key messages: 
➢ Quality is highly subjective and must therefore be applied to the specific context 
of the HMO.  
➢ All interventions and measurements should be developed and analysed with 
stakeholders and locals in order to meet cultural needs and preferences. 
➢ Patient safety, efficiency, patient satisfaction are essential parts of quality man-
agement and should be considered during the HMO’s implementation. 
➢ An HMO should include structures that allow them to analyse, evaluate and meas-





11 Challenges  
11.1 General challenges 
The following paragraphs present several general challenges that must be considered when 
setting up an HMO in West Africa. Due to the fact that the majority of West African countries 
are LMICs there is a notable lack of financial resources for individuals, but also for the 
country in general. More detailed information regarding this was discussed in the Chapter 
5. Poor infrastructure is another issue that can be observed as consequence of lack of 
resources. This affects an HMO by way of problematic transportation, which influences the 
provision of medical equipment and pharmaceuticals, as well as access barriers for pa-
tients. 
The percentage of the population whose earnings depend on agriculture in West Africa 
must also be taken into account, as this varies between 61% and 90% (Table 12). This field 
of work is extremely dependent on various external factors, including not only weather but 
also variations in seed prices and the price farmers are able to sell their products and goods 
for. Therefore, in the case of a failed harvest or other catastrophic event, many people would 
suffer from extreme financial hardship (see 3.2). This uncertain financial situation, which 
affects the majority of the population, is therefore an extreme challenge for the sustainable 
financing of the HMO.  




Burkina Faso 90% 
Guinea 76% 
Guinea-Bissau 82% 
Sierra Leone 61% 
The Gambia 75% 
(Source: Own presentation after The Worldfactbook 2021b, c, d, e, f) 
Most countries are strongly divided into urban and rural regions. While health care workers 
are concentrated in the urban areas, the rural regions of West Africa often suffer from a lack 
of trained health staff. Additionally, the HMO must take into account brain drain not only 
from the villages into cities, but also from within the country to abroad.        
Furthermore, many West African countries have faced a political crisis in the previous dec-




(The Worldfactbook 2021f), the civil war in Guinea-Bissau ended in 1999 (The World-
factbook 2021e) and in 2016 The Gambia emerged from a period of a dictatorship which 
lasted 22 years (The Worldfactbook 2021b). Political uncertainty and instability are still con-
sequences of this turbulent past, in addition to many struggling economies. These issues 
affect the work of an HMO severely, not only due to the weak remaining infrastructure, but 
also because of distrust among the population (Hoddie/Smith 2009: 177). The impact of 
political crises like civil wars have been far-reaching and therefore a detailed discussion 
and analysis in regard to their impacts on an HMO go beyond the scope of this paper.  
Lastly, when talking about general challenges, one has to discuss the different backgrounds 
of those implementing the HMO, as well as its target group. Difficulties are often caused 
when theories or constructs created by non-locals are applied in a target country. This can 
lead to problems such as lack of acceptance by the target group, and the perception of 
treatment methods as being inappropriate, making it essential to work together with local 
individuals or organisations in order to understand and meet the needs of the citizens, and 
accept their culture. Therefore, an HMO must adjust itself to its surroundings in order to 
achieve its set goals. Only when the HMO is accepted by the patients, will it be able to 
provide quality health care. 
11.2 Corruption 
According to the WHO, corruption is defined as “the abuse of entrusted power for private 
gain” (WHO 2018a: 2). Corruption can take place in all HMO departments, for example 
when informal payments are expected by service delivers, or when absenteeism occurs in 
human resources. Studies suggest that corruption is significantly associated with negative 
health outcomes. This demonstrates that corruption not only costs money, but also people’s 
lives (WHO 2018a: 1). In order to prevent corruption, emphasis is placed on ensuring trans-
parency and accountability. This also means that enrolees should be informed about their 
rights, and that swift action is taken when standards are not met. Therefore, it is necessary 
to identify key areas in which corruption plays a role, in order to take preventive measures 
(WHO 2018a: 3 f.). A strategy suggested by WHO is to implement an “anti- corruption” 
hotline within the HMO, for people to report any corruption they face within the system. It is 
important that this hotline provides a safe place for people and anonymity is ensured in 
order to protect whistle-blowers. The acceptance of such hotlines can differ between coun-
tries, and sometimes it may not be possible to reach general acceptance for such a meas-
ure. A low-threshold, easy to access indicator in regard to corruption within the HMO system 
can be taken from Transparency International, which reports on corruption in the health 
care sector annually, within nearly every country (WHO 2018a: 21).  
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12 Conclusion and next steps 
This report discussed the prospects and challenges of implementing an HMO in West Af-
rica. This was achieved not by presenting one HMO in particular, but instead, by discussing 
aspects of this specific health insurance model in regard to different West African countries. 
For example, whilst accreditation was exemplified by Cote d’Ivoire, pharmaceutical man-
agement was illustrated using the example of Liberia. It is important to note that countries 
in West Africa largely face similar challenges concerning their social, political or structural 
environment. Furthermore, the health status of population groups within the region is also 
comparable in many cases. Despite this, it is important to note that observations and pro-
posals for one HMO dimension, that have been elaborated using a specific country setting, 
are not directly transferable to other countries and healthcare situations. Individual adjust-
ments must be made in order to feasibly implement an HMO in a specific setting. In addition, 
as data in the West African setting is often scarce, this report is based on many assumptions 
by the authors. Accordingly, the goal of this report was to provide ideas and to generate 
food for thought. It does not provide concrete, one-size-fits-all solutions for the complex 
process in question, namely the implementation of an HMO in West Africa. However, this 
report can be used as a basis for further in-depth discussions and more specific elabora-
tions regarding the presented topics.  
The private sector encompasses advantages compared to the public sector in LMICs due 
to political instabilities and economic policies that undermine the health departments. Thus, 
the public sector is often understaffed and under facilitated, and incapable of offering high 
quality healthcare services. The unique design of an HMO offers many promising elements 
for this region, as it can provide comprehensive, integrated and coordinated care (Policy 
Scout 2021) with a focus on preventive measures to decrease costs and improve health. In 
addition, an HMO can create a new market for healthcare that offers new employment op-
portunities as well as training for health workers.  
Nevertheless, various pitfalls for the implementation of HMOs in West Africa could be ob-
served. First of all, it remains questionable if citizens would be willing to enrol in a prepaid 
health insurance, as this financing model is still uncommon in West Africa and the willing-
ness to pay for services that might not be required (in a best-case scenario) might be low. 
Besides the willingness to pay, the ability to pay contributions might also limit the reach of 
an HMO. For example, as many people in West Africa work in the agricultural sector and 
thereby do not have a constant income, they are at risk of losing their entire income during 
droughts. Furthermore, scaling up the range of services provided by HMOs may lead to 
challenges regarding available resources in urban and rural areas. It is likely that initially, 
mainly those living in capitals, cities or other urban parts of West Africa will profit from the 
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implementation of HMOs. Accordingly, HMOs must therefore ask themselves difficult ques-
tions regarding the services they offer, as pursuing coverage of a huge variety of services 
might lead to serious inequities if the range of available services is substantially reduced for 
members living in rural areas compared to those in urban areas. Including services within 
a health benefit package that are not available to all beneficiaries can be considered as 
ethically questionable (Krubiner/Faden 2017: 298) and consequently urges HMOs to make 
tough decisions in weighing the range of available services against coverage of diverse 
geographical areas. Additionally, the societal and political instability faced by the region 
overall must be considered, as these issues, along with overall poor infrastructure, pose a 
considerable threat to the successful implementation of a private health insurance in West 
Africa. 
Nevertheless, HMOs have the potential to strengthen the healthcare systems in West Africa 
by providing beneficiaries with quality healthcare services, while at the same time reducing 
their financial burden due to ill-health. Therefore, the authors conclude that HMOs have the 
potential to play a role in enabling West African countries to fulfil their obligation of protecting 
the health of their citizens. However, in order to reach this goal, several aspects must be 
considered. Newly designed HMOs must reflect the cultural, societal and political environ-
ment in which they are implemented. Therefore, it is key to conduct research prior to the 
implementation of HMOs and to include various local stakeholders as early as possible. If 
the values, interests and perspective of the local population are not reflected in the design 
of an insurance, attracting members becomes difficult and the probability of the project fail-
ing increases. Due to the low-income setting, overall available financial resources are lim-
ited in general, making it necessary to constantly monitor the HMO’s monetary flows and 
make necessary adjustments and hence ensure the financial sustainability of the HMO. 
Only in this way can the financial sustainability of an HMO be ensured. Additional measures 
should also be taken in order to prevent informal payments by HMO members to the 
healthcare providers, as well as any other forms of corruption. The trust of the patients 
belonging to the HMO, as well as its image, could be seriously hampered if informal under-
the-counter payments such as these occur alongside the regular payment mechanisms. 
Lastly, an HMO must begin to take steps in preparing itself for foreseeable upcoming chal-
lenges, for example in the context of climate change or new infectious diseases such as 
Ebola or COVID-19. To conclude, it can be envisaged that the successful implementation 
of an HMO in one area could encourage further countries to follow the respective example 
and support similar approaches in their own healthcare context, eventually resulting in a 
domino effect within the region of West Africa.  
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Appendix 1: Actuarial calculations – Guinea-Bissau  
Population projections Guinea-Bissau by sex 2015-2030 
 
male female total growth rate 
 
2015 846,000 891,000 1,737,000 2.66% 
 
2016 869,000 914,000 1,782,000 2.59% 
 
2017 892,000 936,000 1,828,000 2.58% 
 
2018 915,000 959,000 1,874,000 2.52% 
 
2019 939,000 982,000 1,921,000 2.51% 
 
2020 963,000 1,005,000 1,968,000 2.45% 
 
2021 987,000 1,029,000 2,015,000 2.39% 
 
2022 1,011,000 1,052,000 2,063,000 2.38% 
 
2023 1,035,000 1,076,000 2,112,000 2.38% 
 
2024 1,060,000 1,100,000 2,160,000 2.27% 
 
2025 1,085,000 1,125,000 2,209,000 2.27% 
 
2026 1,110,000 1,149,000 2,259,000 2.26% 
 
2027 1,135,000 1,174,000 2,309,000 2.21% 
 
2028 1,160,000 1,199,000 2,359,000 2.17% 
 
2029 1,186,000 1,224,000 2,410,000 2.16% 
 
2030 1,212,000 1,250,000 2,461,000 2.12% 
 
(United Nations 2019)   
      
Population of Guinea-Bissau by age groups: 2015-2030  
 
2015 2020 2025 2030 
 
0-4 285,000 305,000 321,000 336,000 
 
5-14 456,000 520,000 572,000 609,000 
 
15- 59 918,000 1,053,000 1,216,000 1,401,000 
 
60-64 33,000 33,000 37,000 42,000 
 
65+ 46,000 57,000 65,000 73,000 
 
      




 2015 2020 2025 2030  
0-4 16.4% 15.5% 14.5% 13.7% 
 
5-14 26.3% 26.4% 25.9% 24.7% 
 
15- 59 52.8% 53.5% 55.0% 56.9% 
 
60+ 4.5% 4.6% 4.6% 4.7% 
 
65+ 2.7% 2.9% 2.9% 3.0% 
 
(United Nations 2019)  
      
 2015 2020 2021 
% of population in the age of 15-64 54.75% 55.18% 55,38% 
working age (15-64) population  951,008 1,085,942 1.115.907 
population in capital city  342,536 388,028 397.358 




Revenue projections Guinea-Bissau 
 
Formal contributors   2015 2020 2021 2022 2023 2024 2025 
 
 
Number of contributors   187,538.68 214,113.85 220,056.86 226,397.33 233,274.03 239,598.00 245,120.45 
 
 
average national income 
per contributor in local cur-
rency  731,463.00 912,131.00 948,616.24 986,560.89 1,026,023.33 1,067,064.26 1,109,746.83 
 
 
Contribution rate   6% 6% 6% 6% 6% 6% 6% 
 
 
average contribution per 
year per contributor  43,887.78 54,727.86 56,916.97 59,193.65 61,561.40 64,023.86 66,584.81 
 
 
HMO direct revenue  8,230,656,285.44 11,717,992,828.75 12,524,970,689.93 13,401,285,278.53 14,360,675,918.90 15,339,987,728.05 16,321,298,383.73 
 
 
         
 
 
         
 
 






International donors and 
NGOs World Bank  220,241,555.52 231,833,216.34 4,141,575,102.11 4,141,575,102.11 4,141,575,102.11 243,424,877.16 255,596,121.01 
 
 
 GAVI  768,248,636.11 903,693,242.07 842,539,618.48 276,652,762.00 276,652,761.77 290,485,399.86 305,009,669.85 
 
 
 Global Fund 9,149,456,704.78 9,631,007,057.66 10,112,557,410.54 10,618,185,281.07 11,149,094,545.12 11,706,549,272.38 12,291,876,736.00 
 
 
Private donors   384,184.32 400,192.00 416,199.68 432,847.67 450,161.57 468,168.04 486,894.76 
 
 
Earmarked programmes PIMI 4,420,196.35 4,604,371.20 4,788,546.05 4,980,087.89 5,179,291.41 5,386,463.06 5,601,921.58 
 
 
 NGOs 329,152.51 342,867.20 356,581.89 370,845.16 385,678.97 401,106.13 417,150.37 
 
 
Sub-total  10,143,080,429.59 10,771,880,946.47 15,102,233,458.75 15,042,196,925.90 15,573,337,540.95 12,246,715,286.62 12,858,988,493.58 
 
 






Governmental revenues  2015 2020 2021 2022 2023 2024 2025 
 
 
Population income tax 2,592,000,000 2,915,647,488.00 3,032,273,387.52 3,153,564,323.02 3,279,706,895.94 3,410,895,171.78 3,547,330,978.65 
 
 
Ministry of Health  10,982,000 12,353,266.45 12,847,397.11 13,361,292.99 13,895,744.71 14,451,574.50 15,029,637.48 
 
 
        
 
 






Total revenue projections  45.112.417.189,59 56.990.823.940,92 62.520.570.039,38 63.691.668.732,81 65.486.550.027,28 63.457.162.124,72 65.401.076.703,82 
 
 Percentage allocated to 
HMO  5% 5% 5% 5% 5% 5% 5% 
 
 
HMO indirect revenue   2.255.620.859,48 2.849.541.197,05 3.126.028.501,97 3.184.583.436,64 3.274.327.501,36 3.172.858.106,24 3.270.053.835,19 
 
 
Total HMO revenue projections 10.486.277.144,92 14.567.534.025,80 15.650.999.191,90 16.585.868.715,17 17.635.003.420,27 18.512.845.834,28 19.591.352.218,92 
 
           
           
 Notes      
 local currency used - XOF  
 Contributors age of 15-64 
 Income estimated on a 4% growth of GDP  
 estimated growth of contributions of international donors 5%    
 estimated growth of contributions of private donors 4% 




Benefit cost projections 
 2015 2020 2021 2022 2023 2024 2025 
Total budget  10.486.277.144,92 14.567.534.025,80 15.650.999.191,90 16.585.868.715,17 17.635.003.420,27 18.512.845.834,28 19.591.352.218,92 
        
Scenario: coverage of  
all in the capital 342,536 388,028 397,358 406,824 416,486 425,952 435,615 
 
       
Budget for benefit pack-
age (60%) 6.291.766.286,95 8.740.520.415,48 9.390.599.515,14 9.951.521.229,10 10.581.002.052,16 11.107.707.500,57 11.754.811.331,35 
 
Budget for infrastructure 
(10%) 1.048.627.714,49 1.456.753.402,58 1.565.099.919,19 1.658.586.871,52 1.763.500.342,03 1.851.284.583,43 1.959.135.221,89 
 
Budget for administration 
(10%) 1.048.627.714,49 1.456.753.402,58 1.565.099.919,19 1.658.586.871,52 1.763.500.342,03 1.851.284.583,43 1.959.135.221,89 
 
Budget for HMO expan-
sion (10%) 1.048.627.714,49 1.456.753.402,58 1.565.099.919,19 1.658.586.871,52 1.763.500.342,03 1.851.284.583,43 1.959.135.221,89 
 
Budget for reserve (10%) 1.048.627.714,49 1.456.753.402,58 1.565.099.919,19 1.658.586.871,52 1.763.500.342,03 1.851.284.583,43 1.959.135.221,89 
 
Total costs  9.437.649.430,43 13.110.780.623,22 14.085.899.272,71 14.927.281.843,65 15.871.503.078,24 16.661.561.250,86 17.632.216.997,03 
 
per capita costs per pop-






 CASH INFLOW CASH OUTFLOW NET INCOME RESERVE 
 
 Contributions Investment Income Total Revenue  Total Cost 
Net Income (Total Income+ Last 
Year Reserve +Investment In-
come -Total Cost) 
As proportion of next 
year Outflow 
 
 (a) (b) 
(c)=(a)+(b)+Net income from 
previous year (d) (e) (f) 
 
2015 10.486.277.144,92 - 10.486.277.145 9.437.649.430 1.048.627.714 0,08 
 
2020 14.567.534.025,80 - 14.567.534.026 13.110.780.623 1.456.753.403 0,10 
 
2021 15.650.999.191,90 145.675.340 15.796.674.532 14.085.899.273 1.710.775.259 0,11 
 
2022 16.585.868.715,17 171.077.526 16.756.946.241 14.927.281.844 1.829.664.397 0,12 
 
2023 17.635.003.420,27 182.966.440 17.817.969.860 15.871.503.078 1.946.466.782 0,12 
 
2024 18.512.845.834,28 194.646.678 18.707.492.512 16.661.561.251 2.045.931.262 0,12 
 
2025 19.591.352.218,92 204.593.126 19.795.945.345 17.632.216.997 2.163.728.348  
 
       
 Reserve of External contributions   Reserve of Internal contributions    Reserve for Formal Contributions  
2015 50.715.402,15 2015 174.846.684 2015 41.153.281,43 
2020 53.859.404,73 2020 231.094.715 2020 58.589.964,14 
2021 75.511.167,29 2021 237.091.683 2021 62.624.853,45 
2022 75.210.984,63 2022 243.247.359 2022 67.006.426,39 
2023 77.866.687,70 2023 249.566.062 2023 71.803.379,59 
2024 61.233.576,43 2024 256.052.234 2024 76.699.938,64 
2025 64.294.942,47 2025 262.710.441 2025 81.606.491,92 
Notes 
Currency used XOF  
Zins 0.10 





Appendix 2: Actuarial calculations – Sierra Leone 
Demographic projections in Sierra Leone 









 male female total growth rate 
2015   7,092,113 3.2% 
2016 3,591,542 3,704,860 7,296,402 2.9% 
2017 3,691,506 3,807,980 7,499,486 2.8% 
2018 3,790,791 3,910,394 7,701,185 2.7% 
2019 3,889,366 4,012,088 7,901,454 2.6% 
2020 3,987,250 4,113,068 8,100,318 2.5% 
2021 4,084,494 4,213,388 8,297,882 2.4% 
2022 4,181,167 4,313,093 8,494,260 2.4% 
2023 4,277,318 4,412,283 8,689,601 2.3% 
2024 4,373,020 4,511,012 8,884,032 2.2% 
2025 4,468,350 4,609,341 9,077,691 2.2% 
2026 4,563,350 4,707,350 9,270,700 2.1% 
2027 4,658,099 4,805,077 9,463,176 2.1% 
2028 4,752,626 4,902,593 9,655,219 2.0% 
2029 4,846,987 4,999,933 9,846,920 2.0% 
2030 4,941,221 5,097,140 10,038,361 1.9% 
(Source: Togoh et al. 2017: 4-19) 
Population percentage by age groups: 2000-2030 
 2016 2020 2025 2030 
<15 41.5 41.6 40.9 39.5 
15-64 55 55.1 56.1 57.5 
65+ 3.5  3.3 3.1 3 
(Source: Togoh et al. 2017: 24) 
Population by age groups 
 2020 2021 2022 2023 2024 2025 
0-14 3,218,000 3,257,000 3,290,000 3,320,000 3,347,000 3,374,000 
15-65 4,525,000 4,645,000 4,771,000 4,903,000 5,036,000 5,171,000 
65 and above 234,000 239,000 245,000 250,000 255,000 261,000 






(Source: Own calculations) 
Notes: 
- Currency used is Leone 
- BP = Benefit Package 
- Working population = 18-64 years old 
- Insurable income and income per quantile increase yearly by 3% according to increasing GDP growth per 
capita in Sierra Leone (WB) 
- Ministery of finance (MoF) Budget allocation is referred from Saffa 2020: 74 
2020 2021 2022 2023
1. Formal sector (30% of the working population)
number of contributors 1,854,163 1,874,492 1,888,274 1,897,809
Average insurable income per one contributor per year 13,500,000 13,905,000 14,322,150 14,751,815
Contribution rate 6% 6% 6% 6%
Average contributions per one contributor per year 810,000 834,300 859,329 885,109
Total Sum 1,501,871,860,062 1,563,888,294,992 1,622,648,606,427 1,679,767,454,134
Total to BP (60% of sum) 901,123,116,037 938,332,976,995 973,589,163,856 1,007,860,472,481
2.  Informal sector (70% of the working population)
number of contributors in each quantile 865,276 874,763 881,195 885,644
1st income quantile
annual average income 2,938,000 3,026,140 3,116,924 3,210,432
average annual contribution (6%) per contributor 176,280 181,568 187,015 192,626
sub-total 152,530,847,773 158,829,267,530 164,796,993,777 170,598,012,157
2nd income quantile
annual average income 12,708,000 13,089,240 13,481,917 13,886,375
average annual contribution (6%) per contributor 762,480 785,354 808,915 833,182
sub-total 659,755,620,660 686,998,751,454 712,811,503,375 737,903,178,518
3rd income quantile
annual average income 29,053,000 29,924,590 30,822,328 31,746,998
average annual contribution (6%) per contributor 1,743,180 1,795,475 1,849,340 1,904,820
sub-total 1,508,331,763,223 1,570,614,945,387 1,629,627,998,705 1,686,992,527,974
4th income quantile
annual average income 62,493,000 64,367,790 66,298,824 68,287,788
average annual contribution (6%) per contributor 3,749,580 3,862,067 3,977,929 4,097,267
sub-total 3,244,421,466,943 3,378,392,585,347 3,505,329,656,939 3,628,720,753,474
5th income quantile
annual average income 272,586,000 280,763,580 289,186,487 297,862,082
average annual contribution (6%) per contributor 16,355,160 16,845,815 17,351,189 17,871,725
sub-total 14,151,726,913,225 14,736,090,782,476 15,289,773,092,451 15,827,988,339,599
Total Sum 19,716,766,611,824 20,530,926,332,194 21,302,339,245,246 22,052,202,811,723
Total to BP (60% of sum) 11,830,059,967,095 12,318,555,799,316 12,781,403,547,148 13,231,321,687,034
3. External governmental resources
MoF Budget to MoHS 755,289,000 794,178,000 840,013,000 910,967,000
contribution to HMO 5.00% 5.00% 5.00% 5.00%
Total Sum 37,764,450 39,708,900 42,000,650 45,548,350
Total to BP (60% of sum) 22,658,670 23,825,340 25,200,390 27,329,010
4. External non-governmental resources (Global funds and vertical programmes)
Grant allocation 264,156,000 274,017,000 315,183,000 321,658,000
contribution to HMO 5.00% 5.00% 5.00% 5.00%
Total Sum 13,207,800 13,700,850 15,759,150 16,082,900
Total to BP (60% of sum) 7,924,680 8,220,510 9,455,490 9,649,740
If the whole population is enrolled: 
Total revenue projections 21,218,689,444,136 22,094,868,036,936 22,925,045,611,474 23,732,031,897,107
Total revenue projections to BP 12,731,213,666,482 13,256,920,822,162 13,755,027,366,884 14,239,219,138,264
If 10% of population is enrolled:
Total revenue projections 2,121,868,944,414 2,209,486,803,694 2,292,504,561,147 2,373,203,189,711




Benefit cost estimation 
Budget allocation for care packages  
 
(Source: Own calculations) 
 
  
2020 2021 2022 2023
Total revenue projection for Benefit Package 1,273,121,366,648 1,325,692,082,216 1,375,502,736,688 1,423,921,913,826
1. Preventive care 
Budget (20%) 254,624,273,330 265,138,416,443 275,100,547,338 284,784,382,765
2. Primary Health care
Budget (20%) 254,624,273,330 265,138,416,443 275,100,547,338 284,784,382,765
3. Maternal and Child health care
Budget (20%) 254,624,273,330 265,138,416,443 275,100,547,338 284,784,382,765
4. Mental care
Budget (10%) 127,312,136,665 132,569,208,222 137,550,273,669 142,392,191,383
5. Secondary health care/ Tertiary health care
Budget (20%) 254,624,273,330 265,138,416,443 275,100,547,338 284,784,382,765
6. Emergency care




Appendix 3: Service inclusion protocol examples 
Service inclusion protocol for preventive care  
 Deliberation  
Disease Tuberculosis (TB) 
Incidence rates in Sierra Leone in 2017: 23,000 cases 
Possible inter-
ventions  
Tuberculosis screening routine: 
1. Interferon-Y release assays (IGRAs):  
• QuantiFERON Gold (QFT-G) 
• QuantiFERON Gold In-Tube (QFT-IT) 
• T-SPOT-based T-SPOT.TB 
2. Tuberculin skin test (TST) 
Evidence  - TB is often asymptomatic and it has low detection rate.  
- screening is evident as an early detection measure and to save more costs from an 
activated TB cases.  
- IGRAs have higher sensitivity than Tuberculin skin test (TST) especially for detect-
ing latent TB. While TST gives false positive results in people vaccinated with BCG 
and those infected with other mycobacteria diseases. 
Costs Cost-Effectiveness Analysis:  
Total cost per 1,000 screening tests: 
- QFT-IT: US$ 245 
- T-SPOT.TB: US$ 245 
- TST: US$ 240  
Costs saved through screening per future active TB cases prevented:  
- QFT: US$ 50 
- T-SPOT.TB: US$ 48 
- TST: US$ 58 
→ Available remaining budget for preventive care services in 2021:  
US$ 25,000,000 
Discussion - It should be considered that most cost-effectiveness studies were done in HIC.  
 
- The availability of efficient laboratory is a step needed to develop screening routine 
in many health facilities for that good infrastructure as well as health workers is 
necessary.  
 
- Detecting TB cases as early as possible is an effective preventive measure to en-
sure early and continuous treatment.  
 
- IGRAs have higher sensitivity and thus save the costs of further diagnostic 




- Combination of BCG vaccine from the public health sector and routine TB screening 
for high-risk groups and their contacts, HIV positive patients and healthcare workers 




(Source: Own presentation after NICE 2016: 5 ff.; Nienhaus et al. 2011: 1 ff., 6ff., 9ff.; Bloom et al. 
2017, WHO 2018b) 
Service inclusion protocol for primary care  
 Deliberation  
Disease Chronic obstructive pulmonary disease (COPD) 
Possible inter-
ventions  
1. Non-pharmacological management  
• Educational and behavioural activities  
• Pulmonary rehabilitation 
• Oxygen therapy  
• Immunisation - pneumococcal and influenza vaccine yearly 
2. Pharmacological therapy/Inhalers  
• Bronchodilators such as beta 2 agonists, antimuscarinics  
 
Evidence  - Non-pharmacological management increases quality of life and reduces exacerbations 
and complications such as pulmonary hypertension. It improves lung-capabilities. For 
instance, pulmonary rehabilitation increases lung functions which increases patient's 
ability to exercise and oxygen therapy reduces symptoms for patients and improves 
quality of life.  
 
- It is easy to administer which is favourable for self-management plan while improving 
survival with low level of care through.  
 
- Educational and behavioural activities are very crucial in COPD management such as 
smoking cessation.  
 
Costs Cost-Effectiveness Analysis:  
- Effective COPD management in primary care decreases inpatient and medications 
costs.  
 
- Pharmacological treatment has high costs and requires combination of drugs which 
might cause numerous side-effects.  
 
→ Available remaining budget for primary care services in 2021: US$ 25,000,000 
Discussion - Continuous and coordinated care for managing COPD, needs well trained physicians 






- Provision of non-pharmacological and pharmacological therapy guidelines in PHC. In 
addition, referral guidelines to secondary care in case of deteriorated situations.  
 
- Combined therapy is evidently better for managing COPD patients.  
(Source: Own presentation after Burney et al. 2017: 273 ff., 276 ff.; NICE 2018; ur Rehman et al. 





Service inclusion protocol for maternal and child care  
 Deliberation  
Disease Reproductive, Maternal, Neonatal and Child (RMNC) diseases  
Possible inter-
ventions  
1. Community-based care (delivery of comprehensive interventions package) 
2. Health-facility based care  
Evidence  - Community based care can be used to deliver comprehensive and integrated RMNCH 
interventions/ services such as antenatal and postnatal visits; exclusive breastfeeding 
education; continuous child weight measurements; early detection of childhood dis-
eases like diarrhoea and pneumonia and its treatment through education of the admin-
istration of oral rehydration solutions. 
 
- Community-based care have increased healthy practices and care seeking behaviour; 
high early detection, treatment and referral; decrease of neonatal and maternal mor-
tality rates.  
 
- Community-based care is beneficial to link communities with Healthcare facilities. It 
enhances health care seeking behaviour as well as utilization of health care services.  
 
- Community-based intervention packages are highly accepted services by communities 
of LMICs.  
Costs Cost-Effectiveness Analysis:  
- Community-based care are less expensive, higher coverage of population, especially 
vulnerable population, who live in distant areas from health facilities.  
- Costs for community-based care is determined according which services from the 
aforementioned are included. Approximately, mean cost per beneficiary: 
• Maternal and neonatal services – US$ 35 
• Child health services – US$ 4 
 
→ Available remaining budget for maternal and child care services in 2021: US$ 
25,000,000 
Discussion - Important to consider the need to train community health workers as first point of con-
tact to identify common symptoms and administer basic treatments/ therapy and pro-
vide them with basic care kit.  
 
- Complicated procedure to assess cost-effectiveness due to comprehensive of inter-
ventions included and benefits are not easily measurable due to its relatedness to 
other non-healthcare determinants.  In addition, costs per disability-adjusted life year 
(DALY) averted should be compared with Gross domestic product (GDP) per capita of 
the country*. Services included within the community-based package are determined 




- Community-based care is important as first point of contact and facilitates referral sys-
tem in case of need to health-facility based care such as delivery complications. 
 
- It is crucial to implement both types of care in a complementary manner.  
* “Interventions are considered to be cost-effective when the cost per DALY averted is less than per capita gross 
domestic product (GDP) and very cost-effective when less than three times GDP per capita” (Lassi et al. 2016: 
277) 






Service inclusion protocol for mental care  
 Deliberation  
Disease Depression  
Prevalence in Sierra Leone (2017): 240,000 
Possible inter-
ventions  
1. Antidepressants  
 -  Selective serotonin reuptake inhibitors (SSRIs) 
 -  Tricyclic antidepressants (TCAs) 
2. Psychotherapy  
 - Brief psychological interventions 
 - Problem-solving therapy  
 - Cognitive behavioural therapy  
 - Behavioural therapies  
  - Psychodynamic therapies 
  - Interpersonal psychotherapy 
3. Combined treatment  
Evidence  All the above-mentioned treatments are considered efficient in the treatment of depressive 
disorder by the Journal of Disease Control Prevention 3 (DCP-3)  
Costs 
(All presented 
prices are just ap-
proximations and 
do not reflect real-
ity) 
Cost-Effectiveness in Sub-Saharan Africa 
Cost per healthy life year gained, 2012: 
1. Antidepressants:  
 - SSRIs: US$ 1390 
 - TCAs: US$ 1410   
2. Psychotherapy:  
 - Episodic psychosocial treatment (EPT) in primary care: US$ 2190 
3. Combination:  
 - EPT + SSRIs: US$ 2140  
 - EPT + TCAs: US$ 2080 
 
Budget Impact Assessment (for annual costs):  
→ Available remaining budget for Mental Health Services in 2021: US$ 12,500,000 
1. Antidepressants:  
 - SSRIs (e.g. Fluoxetine): US$ 16a x 24,000 = US$ 384,000 
  -> 95 %: US$ 364,800 
 - TCAs (e.g. Amitriptyline): US$ 16b x 24,000 = US$ 384,000                 
-> 95 %: US$ 364,800 
2. Psychotherapy:  




  -> 95 %:US$ 273,600 
3. Combination:  
 - EPT + SSRIs: US$ 384,000 + US$ 288,000 = US$ 672,000 
  -> 95 %: US$ 638,400 
 - EPT + TCAs: US$ 384,000 + US$ 288,000 = US$ 672,000 
> 95 %: US$ 638,400   
Further 
relevant points 
for discussion  




• First line treatment with SSRIs  
• Second line treatment with TCAs  
• Long term goal: Training health care workers to make high quality non-medication mental 
health care services available for all insured people 
SSRIs=Selective serotonin reuptake inhibitors; TCAs=Tricyclic antidepressants; DCP-3=Journal of Disease 
Control Prevention 3; EPT=Episodic psychosocial treatment 
a price for 12 x 30 tablet package 
b price for 4 x 100 tablet package  
c price assumption for 1 monthly session of one hour 
(Source: Own presentation after Hyman et al. 2017: 74 ff.; IMPPG 2016a; IMPPG 2016b; 
Levin/Chrisholm 2017: 226 ff.; WHO 2017c; WHO 2020) 
Service inclusion protocol for secondary and tertiary care 
 Deliberation  
Disease Acute stroke treatment  
Incident Cases in Sierra Leone (2016): 3870 (≈4000) 
Possible inter-
ventions  
1. Ischemic Stroke (IS): Oral aspirin intake 
2. IS: Tissue plasminogen activator (tPA) (0.9 milligram per kilogram of body weight; max-
imum of 90 milligrams) (e.g. Alteplase) 
3. Haemorrhagic Stroke (HS): Intensive blood pressure–lowering treatment (e.g. Labetalol) 
4. Treatment in a stroke unit 
Evidence  1. Reduction in 14-day morbidity and mortality + reduction in the risk of a reoccurrence 
2. tPA is the only therapeutic agent approved for arterial recanalization in acute IS. 
3. Treatment with intensive blood pressure lowering interventions attenuated hematoma 
growth for 72 hours  
4. Patients treated in stroke units are more likely to o be alive, independent, and living at 






prices are just ap-
proximations and 
do not reflect real-
ity) 
Cost-Effectiveness Analysis: 
1. Oral Aspirin Intake: Cost effectiveness ratio in Sub-Saharan Africa: > $PPP 6000 per 
DALY adverted 
2. Incremental Cost effectiveness ratio in Iran: $ 8,471 per QALY 
3. No information on cost-effectiveness could be found 
4. Provision of organised stroke unit care: Cost effectiveness ratio in Sub-Saharan Africa: 
> $PPP 6000 per DALY adverted 
 
Budget Impact Assessment:  
->Available remaining budget for Secondary& Tertiary care in 2021:  
US$ 25,000,000 
 
1. Oral Aspirin Intake:  Medication: US$ 0,01a) x 400 = US$ 4 
   Inpatient care costs: US$ 2205b) x 400 = US$ 882,000 
   Total= US$ 882,004 
   -> 90 %: US$ 793,804 
 
2. Treatment with Alteplase:   
   Medication: US$ 12,105 x 400= US$ 4,842,000                                                      
Inpatient care costs: US$ 2205b) x 400 = US$ 882,000    
Total= US$ 5,724,000 
   -> 90 %: US$ 5,151,600 
 
3. Intensive blood pressure–lowering treatment with Labetalol: 
    Medication: US$ 4,5 x 400 = US$ 1800 
                                      Inpatient care costs: US$ 2205b) x 400 = US$ 882,000  
                                      Total = US$ 883,800 
   -> 90 %: US$ 795,420 
 
4. Episodic treatment in stroke unit:   
   Medication: US$ 7890 x 400= US$ 3,156,000 
                                      Inpatient care costs: US$ 2205b) x 400 = US$ 882,000 
                                      Total = US$ 4,038,000  




Discussion System level barriers for the implementation of stroke units as for example a lack of physi-
cians must be considered and make this intervention not suitable for inclusion in compari-
son with other treatment options. Nevertheless, their implementation should be considered 




For IS: Oral Aspirin intake   
For HS: Intensive blood pressure lowering interventions (other treatment options should be 
regularly monitored to find more effective treatment options) 
IS=Ischemic Stroke; HS=Haemorrhagic Stroke; tPA=Tissue plasminogen activator 
$PPP= Purchasing power parity US$; DALY=disability-adjusted life year; QALY=quality-adjusted life year 
a) Price approximation for one tablet 
b) Approximation with data from South Africa 
(Source: Own presentation after Amiri et al. 2018: 284 ff.; GBD 2016 Stroke Collaborators 2019: 448; 
IMPPG 2016c; IMPPG 2016d; Kleindorfer et al. 2017: 2000 ff.; Maredza/Chola 2016: 31 f.; Ortegón 
et al. 2012: 5 ff.; Puumalainen et al. 2020: 4; Yan et al. 2017: 165 ff.) 
 
 
 
